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ABSTRACT1  
Ca2+-permeable AMPA-type glutamate receptors (CP-AMPARs) containing 
GluA1 but lacking GluA2 subunits contribute to multiple forms of synaptic plasticity, 
including long-term potentiation (LTP), but mechanisms regulating CP-AMPARs are 
poorly understood. A-kinase anchoring protein (AKAP) 150 scaffolds kinases and 
phosphatases to regulate GluA1 phosphorylation and trafficking, and trafficking of 
AKAP150 itself is modulated by palmitoylation on two Cys residues. Here, we 
developed a palmitoylation-deficient knock-in mouse to show that AKAP150 
palmitoylation regulates CP-AMPAR incorporation at hippocampal synapses. Using 
biochemical, super-resolution imaging, and electrophysiological approaches, we found 
that palmitoylation promotes AKAP150 localization to recycling endosomes and the 
postsynaptic density (PSD) to limit CP-AMPAR basal synaptic incorporation. In addition, 
we found that AKAP150 palmitoylation is required for LTP induced by weaker 
stimulation that recruits CP-AMPARs to synapses but not stronger stimulation that 
recruits GluA2-containing AMPARs. Thus, AKAP150 palmitoylation controls its 
subcellular localization to maintain proper basal and activity-dependent regulation of 
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CHAPTER I  
INTRODUCTION 
Hippocampus: circuitry and relevance in learning and memory 
Decades of research have gone into the study of learning and memory but 
despite this extended focus, the cellular and molecular mechanisms by which learning 
and memory take place remain incompletely characterized. Much research has focused 
on the hippocampus, the distinctive limbic structure in the medial temporal lobe of the 
brain, as the epicenter of memory formation. At the circuit level in humans, focal 
hippocampal lesions result in recall and memory deficits 2. Further evidence supporting 
learning and memory function of the hippocampus in humans are the profound deficits 
in patients with developmental and neurodegenerative diseases. At the synaptic level, 
the plasticity of synapses within the hippocampus in response to activity is thought to 
underlie learning and memory processes3,4.  
 The structure of the hippocampus in the rodent is classified as a tri-synaptic loop 
(Fig 1.1). The primary input to the hippocampus comes from neurons in the entorhinal 
cortex (EC) that synapse onto cells in the dentate gyrus (DG) which in turn send axons 
to pyramidal cells within the Cornu Ammonis (CA) area 3 (CA3). These CA3 neurons 
then form excitatory synapses onto pyramidal neurons within the CA1 area, called the 
Schaffer collaterals. The CA1 neurons pass information through the subiculum, which 
send projections back to the EC, other parts of the cortex, and within the hippocampus 
itself. Due to this simple and well-defined circuitry, the rodent hippocampus has become 





Figure 1.1: Structure of the rodent hippocampus. 
The rodent hippocampus is organized into a tri-synaptic loop. The first part of the loop 
comes from the major input to the hippocampus, the entorhinal cortex, via the perforant 
path. Axons from the perforant path synapse onto granule cells in the dentate gyrus that 
then synapse via axons called mossy fibers onto CA3 pyramidal neurons forming the 
second synapse of the tri-synaptic loop. The final synapse within the loop originates 
from CA3 neuron axons called Schaffer collaterals forming connections with CA1 
pyramidal neurons. This final synapse is one of the most studied synapses in all of 
neuroscience and has been found to be important for learning and memory. From here, 






Pyramidal neurons, or principal neurons, within the hippocampus receive 
excitatory input in the form of an electrochemical signal (Fig 1.2). Pre-synaptic input 
converges on the dendrites of pyramidal neurons resulting in the modification of 
connectivity and activity. These dendrites reach out 100s of microns from the soma and 
are highly branched and complex. Dendrites are decorated with small, independent 
compartments forming protrusions on the shaft called dendritic spines (1-10 
spines/micron of dendrite in primary neurons). Dendritic spines are the sites of 
excitatory synapses, formed when a post-synaptic spine forms contact with a pre-
synaptic axon. Dendritic spines are quite heterogeneous structures, undergoing 
number, size and shape alterations throughout development and in response to activity. 
Axons can also form synapses onto the shaft of the dendrite, often the sites of inhibitory 
synapses. Synapses within the central nervous system are classified by the 
neurotransmitter and signaling action downstream. Here, excitatory synapses will refer 
to glutamatergic synapses and inhibitory synapses will refer to gamma-Aminobutyric 
acid (GABA)-ergic synapses. Inhibitory synapses help to balance neuronal activity by 
dampening neuronal firing. Inhibitory synapses form predominately on the dendritic 
shaft, as opposed to forming on dendritic spines like excitatory synapses. Their 
molecular organization and composition are distinguishable and distinct from excitatory 
synapses. During the experiments outlined in this thesis, inhibitory synapses were either 
not examined or pharmacologically inhibited to isolate excitatory contributions. 






Figure 1.2: Excitatory synapses in CA1 of the hippocampus.  
A closer look at neurons within the CA1 region of the hippocampus will reveal a clear 
laminar organization of the cell body layer containing mostly excitatory, pyramidal 
neurons. Schaffer Collaterals synapse onto dendrites of these CA1 neurons. A. A 
schematic showing a general and simplified excitatory synapse made up of an axon, 
synaptic cleft, and post-synapse. The post-synaptic density is shown in the post-
synaptic dendritic spine containing glutamatergic ion channels. B. When the pre-
synaptic neuron fires an action potential, the pre-synaptic bouton experiences an 
increased calcium concentration, causing vesicles containing the neurotransmitter 
glutamate to fuse with the membrane and glutamate to diffuse across the synaptic cleft. 
The glutamatergic ion channels bind the neurotransmitter and cause cations to flow into 





Synapses are incredibly complex structures, but can be broken down into three 
essential components: the pre-synaptic terminal, the synaptic cleft and the post-synaptic 
compartment (Fig 1.2A).  
Pre-synaptic terminal 
The pre-synaptic axon terminal contains neurotransmitter vesicles that dock and 
fuse at the active zone to pass a chemical signal to the post-synaptic spine. The pre-
synaptic terminal receives electrical information by way of an action potential (AP) and 
transmits the signal via neurotransmitter release. Ca2+ entry into the pre-synaptic 
terminal is mediated by depolarization caused by the conduction of the AP to the pre-
synapse, which opens voltage-gated Ca2+-channels and triggers Ca2+-dependent 
exocytosis of neurotransmitter containing vesicles. Electron microscopy shows ~40 nm 
docked synaptic vesicles that defines the pre-synaptic specialization, the active zone 
(AZ). The AZ is directly apposed to the electron dense thickening of the post-synaptic 
membrane, at the interface between the pre-synaptic terminal and the synaptic cleft. 
Vesicle fusion takes place within less than 1 ms after AP-mediated pre-synaptic 
depolarization; thus, vesicles need to be close to release sites and the machinery 
required for fusion must be spatially and temporally regulated. Exocytosis of synaptic 
vesicles is limited to small membrane domains containing the molecular machinery and 
lipid composition to facilitate exocytosis where pre-docked vesicles (termed the “readily 
recruitable” pool of vesicles) fuse. There can be one or multiple exocytic sites per pre-
synaptic terminal. Fusion sites tend to be situated near the AZ5 however individual 
exocytic events are not confined to a single release site6-8. Among the molecular 




Generally, it is thought that the pre-synaptic AZ is organized by a handful of protein 
families9,10 including: RIM proteins, RIM-BP, Munc 13s, ELKs, Bassoon and Piccolo. 
Each protein family plays a role in organizing the pre-synaptic AZ to target vesicle 
fusion to particular sites by scaffolding vesicles, tethering/targeting Ca2+ channels, 
attaching vesicles to the membrane. This exquisite control of pre-synaptic 
neurotransmitter release allows for synapses to encode many different types of 
information, such as different action potential firing patterns. While these pre-synaptic 
events are incredibly important and are intimately tied to post-synaptic responses, the 
majority of this thesis will explore post-synaptic alterations during plasticity.  
Synaptic cleft 
The AZ and post-synaptic density are separated by about 20-25 nm, classified as 
the synaptic cleft. The cleft is not just an empty space between pre- and post-synapse; 
instead, the cleft is enriched with proteins. There are many protein structures spanning 
the cleft, organized in an irregular array. In fact, at the cleft there are electron dense 
regions, including at the periphery, perhaps suggesting distinct functional 
microdomains.  Among the proteins spanning the cleft are cell adhesion molecules that 
form trans-synaptic complexes. This participation of pre- and post-synaptic proteins in 
trans-synaptic interactions is thought to stabilize the synapse and could potentially 
contribute to the alignment of functional domains between release sites and receptors10. 
The cleft has been found to participate in spine formation, maturation and transmission. 
Post-synaptic compartment 
 The post-synaptic component of the synapse is formed onto dendritic spines and 




contained there within. This protein assembly is most dense halfway between the pre- 
and post-synaptic membranes11,12. Glutamatergic synapses in the central nervous 
system (CNS) have prominent PSDs and are thus termed asymmetric synapses, due to 
the disproportionate electron density between the pre- and post-synapse. The PSD can 
range in size ~200-800 nm (with an average of ~300-400 nm) in diameter and ~30-50 
nm thick13. Though relatively small, PSDs are highly specialized areas of the membrane 
that are incredibly abundant (between 10,000 and 100,000/neuron)13 . After the early 
observations of electron density at the post-synaptic membrane, many efforts were 
focused to elucidate the proteins that made up this interesting post-synaptic feature. 
In the 1970’s, the first PSD purification experiments were carried out and in the 
1990’s PSD components began to be identified. Owing largely to the development of 
mass spectrometry, many PSD proteins have been identified in the past few decades. 
The proteins that provide the electron density and namesake for the PSD (with the 
average PSD having a molecular mass of ~1 gigadalton14) include receptors, 
scaffolding proteins, channels, cell adhesion molecules, cytoskeletal elements and 
enzymes. A key scaffold and marker of excitatory PSDs is Post-synaptic density protein 
95 (PSD-95). However, there are 100-1,000s of proteins that occupy and makeup the 
PSD, especially when different brain regions and distinct cell types exhibiting different 
PSD compositions are considered. 
Proteins are dynamic within the PSD, with proteins changing over seconds or 
hours, due to developmental regulation or activity-dependent rearrangement. While we 
now appreciate a whole host of the molecular players within the PSD, we still do not 




that within the post-synapse exists distinct regions: synaptic, perisynaptic (within 100 
nm of the PSD)13 and extrasynaptic. These distinct synaptic subregions are in dynamic 
flux and are functionally connected. Following with this segmentation of the synapse, 
proteins are not homogenously distributed throughout the PSD. Core synaptic regions 
contain glutamate receptors and signaling proteins directly opposed glutamate release, 
while extrasynaptic regions contain metabotropic receptors and endocytic proteins.  
 Continuing with the flow of information from pre-synapse to post-synapse, once 
an AP causes Ca2+ influx in the axon causing neurotransmitter release, glutamate 
diffuses across the synaptic cleft and binds to receptors within the post-synaptic 
membrane (Fig 1.2B). Therefore, a key component of the PSD is the glutamate 
receptors that receive the pre-synaptic chemical signal on the post-synaptic neuron. 
The predominant glutamate receptors are the ionotropic α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptors (AMPARs) and N-methyl-D-aspartate receptors 
(NMDARs). Initially, AMPARs are activated by glutamate binding and allow Na+ into the 
post-synaptic spine, which causes the membrane potential to become more positive or 
depolarized. This depolarization results in the Mg2+-ion that resides in the pore of the 
NMDAR at more hyperpolarized conditions to be displaced, allowing Ca2+ and other 
ions to enter the cell through the NMDAR. The influx of Na+and Ca2+ through post-
synaptic AMPARs and NMDARs initiates a number of signaling cascades and also 
advances the electrical signal to the rest of the neuron via membrane depolarization, 
which can result in AP firing in the post-synaptic neuron to initiate synaptic transmission 





Ionotropic glutamate receptors are integral membrane proteins that form ion 
channels from 4 individual subunits coming together to form an ion pore15. Each subunit 
is composed of 4 domains: amino (N)-terminal domain (NTD), a highly conserved 
extracellular clamshell-like ligand binding domain (LBD), transmembrane domain (TMD) 
and the intracellular carboxy (C)-terminal domain (CTD) (Fig 1.3). These receptors form 
as tetramers, composed of four individual subunits of the same receptor type. There are 
4 classes of glutamate receptors: AMPA receptors, kainate receptors, NMDA receptors, 
and δ-receptors. Glutamate receptors are activated first by ligand binding to the LBD. 
Agonists of glutamate receptors are: glycine, D-serine, aspartate and glutamate. Once 
agonist binds, the LBD changes conformation causing the ion channel domain to open. 
Post-synaptic currents (such as current carried by AMPARs and NMDARs) are 
determined by multiple factors including: receptor number, probability of agonist bound 
and receptor opening, driving force, and conductance of channels. This section will 
focus on AMPA and NMDA receptors, the two predominate ionotropic receptors of 
excitatory pyramidal neurons within the hippocampus that are known to be important in 
baseline neuronal function and during plasticity. 
AMPA receptors 
AMPA receptor properties and assembly  
AMPARs are expressed in neurons throughout the CNS. Under normal 
conditions, AMPARs are the primary mediators of fast excitatory glutamatergic 
neurotransmission within the brain. Due to their rapid kinetics, opening and closing on 





Figure 1.3: Ionotropic glutamate receptor structure.  
Left, a single subunit of a general ionotropic glutamate receptor is shown. Right, 
ionotropic glutamate receptors form tetramers with their NTDs and LBDs protruding into 







synaptic membrane and thus a high-fidelity propagation of signaling between pre- and 
post-synaptic neurons. AMPARs form tetramers of homo-and heterodimers composed 
of GluA1-4 subunits (genes Gria1-4), and are thus called dimers of dimers15,16. Channel 
opening depends on glutamate binding to all subunits of the tetramer17. Each subunit 
contributes differently to receptor properties like channel kinetics, ion selectivity and 
trafficking. Accompanying subunit specific properties, heterodimerization, mRNA 
processing, auxiliary proteins and phosphorylation can add additional complexity to 
subunit control of receptor properties. AMPARs have four distinct domains (as 
mentioned generally above): ECR (extracellular region) that makes up the majority of 
the receptor (~85% of its mass, protruding 130 Angstroms into the synaptic cleft)18,19 
containing the NTD that drives dimerization, TMD and then a CTD that varies in length 
and is highly modified15,20,21 (Fig 1.3). 
AMPARs synaptic number varies widely from synapse to synapse and cell to 
cell13. With >10,000 synapses on each neuron, each synapse must independently and 
dynamically regulate synaptic AMPAR content22. Therefore, the logistics of delivery, 
retention and removal of individual receptors with particular subunit composition and 
channel characteristics is highly complex and requires a considerable amount of 
regulation. AMPARs are highly mobile and their synaptic abundance in highly regulated 
developmentally, basally and in an activity-dependent manner. Much work has gone 
into understanding AMPAR trafficking and how subunit composition can influence 
properties of AMPARs. 
AMPARs can be edited at the RNA level, which precedes mRNA splicing and 




and Glutamine/Arginine/Asparagine site in the membrane re-entrant pore loop of GluA2 
(Fig 1.4A). Editing at this 607 position in the pore loop results in Glutamine to Arginine 
(Q/R) that controls Ca2+-permeability and conductance through the pore and as well as 
affecting receptor assembly to favor heterodimerization over homodimerization and may 
have increased endoplasmic reticulum (ER) residency15. Q/R editing has also been 
shown to be necessary for organism survival23. Further, alternative splicing of AMPAR 
subunits can result in two isoforms; splice variants of the AMPARs have changes within 
the LBD and are called flip and flop and differ in desensitization, deactivation and 
sensitivity to allosteric inhibitors. AMPARs pass cations, such as Na+, K+ and Ca2+, 
which are gated by the GluA2 subunit. Most GluA2 subunits are Q/R edited resulting in 
low Ca2+-permeability (or Ca2+-impermeable AMPARs, CI-AMPARs) and insensitivity to 
block by polyamine blockade. Unedited GluA2 containing receptors (the minority of 
GluA2 subunits) are highly Ca2+-permeable and insensitive to polyamine blockade. 
Alternatively, GluA2-lacking and GluA1-containing receptors (or Ca2+-permeable 
AMPARs, CP-AMPARs) are highly Ca2+-permeable (though less than NMDARs15,24) 
and sensitive to channel block by polyamines and polyamine (philanthotoxin (PhTx), 
joro spider toxin, argiotoxin, IEM-1460, 1-naphthylacetyl-spermine (NASPM))25-32. 
These polyamine-derivatives can extracellularly block CP-AMPARs and are useful to 
probe receptor subunit composition28,33-36. AMPARs have a reversal potential at 0 mV 
and at more depolarized membrane potentials, endogenous polyamines block the pore 
of the GluA1-containing AMPARs in a voltage-dependent manner preventing outward 





Figure 1.4: AMPAR structure and characteristics. A. AMPAR specific subunit 
structural domains. B. AMPARs containing the GluA2-subunit are unable to pass 
calcium due to the positive charge of the arginine residue within the pore, causing a 
linear current-voltage relationship. AMPARs lacking the GluA2-subunit can pass 
calcium and have a non-linear current-voltage relationship. C. Schematic of the CTDs of 









current is called inward rectification (Fig 1.4B). Subunit composition can regulate single 
channel currents with GluA1 homomers conducting an average of ~12 picosiemens (pS) 
and GluA1/2 heteromers passing much less at ~3 pS21. It appears the majority of 
AMPARs are heteromeric GluA2-containing receptors with low Ca2+-permeability and 
low single-channel conductance. However a small number of Ca2+-permeable, GluA2-
lacking receptors with high single-channel conductance form a significant minority and 
play a critical role in signaling, plasticity and disease37-39. GluA4 containing subunits are 
developmentally regulated and sparsely expressed at glutamatergic synapses, but are 
important in AMPAR-mediated transmission in interneurons40. 
AMPAR protein turnover is between 10 hours and 2 days depending on the 
neuron type and developmental age22. Though the basic machinery for the production of 
transmembrane proteins is highly conserved in eukaryotic cells, including neurons, the 
unique structure and function of neurons renders the secretory pathway to be more 
complex41. The precise mechanisms governing AMPAR subunit assembly still are not 
well understood. But we do know that AMPAR subunit assembly occurs in the ER, as 
with other transmembrane proteins. It is assumed that the AMPAR receptor subunits 
initially form homodimers that can eventually rearrange into heterodimers. The NTD of 
the AMPAR subunit drives initial dimerization, with the NTD of different subunits having 
varied affinities for assembling with other subunits15. For example, in hippocampal 
pyramidal neurons GluA1 has much higher affinity for GluA2 than other GluA1 partners, 
which is thought to bias receptor composition toward GluA1/2 heteromer assembly and 
result in more GluA2 containing receptors16 and low levels of GluA2-lacking receptors42. 




receptors have either no GluA2 subunits or two GluA2 subunits43-45. Flexibility in the 
NTD dimer interface allows for the formation of GluA2-lacking receptors46. Because 
GluA2 subunits must undergo editing, these subunits are retained in the ER for longer 
than GluA1 homomers that do not undergo editing and thus can be exported rapidly to 
the plasma membrane (PM)47. The edited GluA2 is mostly unassembled and retained in 
the ER allowing more dwell time and increased chance of interaction with GluA1 to also 
promote heterodimerization with GluA1 to facilitate ER export44,48,49. In other cell types 
with less ER retained GluA2, there are fewer GluA2 containing receptors24. There also 
exist ER chaperones that control AMPAR subunit ER retention such as BiP and 
calnexin47.  
From the ER, AMPARs are trafficked to the Golgi where receptors can be further 
modified. Because neurons are large highly polarized cells, membrane proteins must 
navigate long distances to get to the PM. It still remains unclear where AMPARs are first 
inserted once at the membrane. Membrane insertion is subunit dependent with GluA2-
containing receptors rapidly and constitutively inserted50,51 and GluA2-lacking receptors 
added to the synapse in an activity-dependent, regulated manner. GluA1 subunit rules 
seem to dominate when GluA1 is part of a complex with GluA2. This activity-dependent 
trafficking will be described later in the following plasticity section.  
AMPAR variable CTD contributes to subunit regulation  
Because AMPAR subunits are homologous, the highly variable C-terminal tail is 
thought to be a site of distinct regulation between the subunits conferring receptor 
regulation, including membrane targeting, stabilization, and degradation. AMPAR 




domains that facilitate protein-protein interactions52 (Fig 1.4C). AMPARs (and NMDARs, 
as well) can interact with a number of post-synaptic proteins, such as scaffolds, 
cytoskeletal elements, adaptors, anchors, and enzymes. GluA1 and GluA4 have long C-
terminal tails and GluA2 and 3 have short tails. Initially, NMDARs were identified as 
binding to PSD-9553 through their CTD and AMPAR GluA1 subunits showed 
interactions with Synapse-associated protein 97 (SAP97)54. PSD-95 was the founding 
member of synaptic proteins containing PDZ domains, modular protein-protein motifs, 
which serve as scaffolds at the synapse55,56. These PDZ domains bind to the C-termini 
of ion channels, such as NMDARs and AMPARs. A large family of highly homologous 
PDZ-containing proteins has been identified at the synapse called Membrane-
associated guanylate kinase (MAGUK) proteins. The MAGUKs include PSD-95, Post-
synaptic density protein 93 (PSD-93), Synapse-associated protein 102 (SAP102) and 
SAP97. The functions of MAGUKs have some overlap56,57 and their expression is 
important for AMPAR targeting to the synapse. For example, if PSD-95 is 
overexpressed, synapse formation is increased along with increases in AMPAR levels 
at the synapse58,59. AMPAR GluA1 CTD can also directly interact with transmembrane 
AMPAR regulatory proteins (TARPs), to influence receptor dynamics (discussed more 
below). 
  CTD phosphorylation of different AMPAR subunits can differentially regulate their 
channel properties and localization. GluA1-4 subunits are phosphorylated at over 20 
serine, threonine, and tyrosine residues by many kinases, such as Calcium/calmodulin-
dependent protein kinase II (CaMKII), Protein Kinase A (PKA), Protein Kinase C (PKC), 




N-terminal kinase (JNK)20,60. GluA1 CTD phosphorylation has been extensively studied 
with three sites prominently featured (Fig 1.4C): Serine 818 (S818), Serine 831 (S831), 
and Serine 845 (S845). S818 is phosphorylated by PKC and is important for GluA1 
synaptic incorporation during plasticity61. CaMKII and PKC phosphorylate S831, which 
is thought to increase single channel conductance and could affect receptor surface 
delivery61. S845 is phosphorylated by PKA and is involved in both regulation of open 
probability62 and receptor trafficking15. It has been determined that ~15% of receptors 
are phosphorylated at S831 and S845 at rest63. As detailed below, these 
phosphorylation events appear to play a critical role in controlling receptor function, 
particularly during synaptic plasticity.  
The GluA2 subunit CTD can also be modulated by phosphorylation at Tyrosine 
876 by Src and Serine 880 by PKC, which regulates protein-protein (Glutamate 
Receptor Interacting Protein [GRIP1]/AMPAR Binding Protein [ABP]) interactions. 
GluA2 can be further regulated by protein-protein interactions in the CTD. In the 1990’s, 
yeast two-hybrid screens identified a number of AMPAR interacting proteins, including 
the PDZ interaction between GluA2 and 3 and GRIP 1 and 2 and Protein Interacting 
with C Kinase (PICK1)64-69. N-ethylamine-Sensitive Factor (NSF) is an ATPase that is 
required for membrane fusion interacts with the C-terminus of GluA2. In that same 
region AP2, a protein required for clathrin-dependent endocytosis, interacts with GluA2. 
This GluA2-NSF interaction is important in maintaining AMPAR content at the 
synapse69-75. PKC phosphorylation of GluA2 within the PDZ domain disrupts the binding 




AMPAR synaptic organization 
With the advent of super resolution techniques (such as Photoactivated light 
microscopy (PALM)/Stochastic optical reconstruction microscopy (STORM) and 
Stimulated emission depletion (STED) microscopy) and proteomics, there have been 
profound discoveries about the organization and identification of new proteins within 
synapses. AMPARs are concentrated at the synapse directly opposite of pre-synaptic 
terminals such that pre-synaptic glutamate release is tightly coupled to receptor 
activation10. AMPARs are only a few fold more enriched in the PSD than the periphery. 
But within the synapse, receptors organize into high-density “hotspots”, termed 
nanodomains or nanoclusters, the clustering of which depends on a number of protein-
protein interactions78-80. There are ~1-3 nanodomains per PSD, averaging 80-100 nm in 
diameter and tend to be at the periphery but can be localized anywhere within the 
synapse. It is thought that there are 10s of receptors per ~100 nm radius nanodomains 
spaced ~20 nm from center-to-center10,53,81. Larger synapses with more than one 
central PSD domain tend to have more AMPAR nanodomains7,78,79. PSD-95 itself can 
form nanodomains, but not as well defined as receptor clusters. These PSD-95 
nanodomains are ~80 nm and an average of 1-3 exist in a synapse78. Studies have 
determined that PSD-95 patterning can influence AMPAR distribution7,78,79,82. A number 
of factors can affect PSD-95 (and MAGUK family) nanoclustering and this clustering can 
influence the localization and distribution of a number of proteins due to the extensive 
protein-protein interactions between these synaptic scaffolds and other important 
synaptic proteins. PSD molecule clusters are highly variable between neurons and even 




synapse is composed of multiple independent trans-synaptic modules that form 
individual AMPAR transmission units. The AMPAR nanodomain hypothesis claims that 
activation of receptors within these hotspots can beat desensitization of the channel and 
therefore generate a quantal current. Super-resolution imaging78,79,83 supports the idea 
of the alignment of “nanocolumns”7 or trans-synaptic modules84. 
AMPARs are on average highly mobile so it stands to reason that there are 
proteins at the synapse that must act to retain receptors and restrict their mobility to 
organize and position the receptors within the PSD. In support of this idea, AMPAR 
mobility is restricted within PSD nanodomains but more mobile in between the 
nanodomains79,85. These receptors stay immobile for long periods of time within the 
PSD nanodomains86-88. In this way, synaptic scaffolds (like PSD-95) could serve as a 
building block of synapses by assembling receptors (like AMPARs) at the sites of 
neurotransmitter release10. This could be orchestrated by direct PSD-95 binding89 or 
due to physical diffusion barrier90. It seems rational that macromolecular crowding is at 
play as it could explain why proteins with no PSD-95 binding have lower mobility in 
crowded portions of the PSD91. Further, the NTD of AMPARs can participate in a 
number of protein-protein interactions once the AMPAR is at the synapse, including 
interacting with cell adhesion molecules (CAMs) that are pre- and post-synaptic 
transmembrane proteins like neurexins or cadherins that could also aid in stabilizing 
AMPARs at the synapse. 
Auxiliary proteins 
AMPARs participate in protein-protein interactions with a number of proteins 




subunits can determine receptor gating, channel conductance, sensitivity to 
pharmacological agents and expression at the synapse92. Multiple auxiliary protein 
families exist including transmembrane AMPAR regulatory protein family (TARPs) and 
cornichons. AMPARs assemble with auxiliary subunits early on in receptor biogenesis. 
The collection of AMPARs and associated auxiliary proteins is thought to number >30 
different proteins within an AMPAR complex92. The classic TARP family of AMPAR 
auxiliary proteins can interact with all four GluA subunits at a number of interfaces, 
extracellular, intracellular and at the TMD of both types of proteins. AMPARs can 
interact with 1-4 TARPs, which can control desensitization of the receptor93. The 
receptors themselves do not directly interact with PSD-95 but do so indirectly via 
TARPs as well as direct binding to the other synaptic MAGUK, SAP97. And in this way, 
TARPs can also influence accumulation of AMPARs at the synapse via this MAGUK 
interaction. TARPs themselves can be modified and are differentially expressed across 
different brain regions and cell types and different types of TARPs can interact with 
different receptor assemblies. Further, TARPs can be regulated by CaMKII and PKC 
phosphorylation on multiple sites on the cytoplasmic C-terminal tail of TARPs, which 
can control both constitutive and activity-dependent AMPAR trafficking94,95.  
Outstanding questions 
While decades of research have gone into understanding AMPAR biogenesis, 
trafficking and regulation, many outstanding questions still exist. Though many studies 
have provided seminal and foundational knowledge about AMPARs, there needs to be 
a re-examination of AMPAR regulation using manipulations that do not perturb 




unknown how the subunit composition of AMPARs is regulated rapidly and 
independently at the single synapse level. And it is still not understood if there are 
specific receptor reserves that can be tapped into under different conditions, such as 
during extremely high activity states. Further, how the subunit composition of locally 
synthesized receptors is controlled and how those locally synthesized receptors are 
incorporated into the synapse still remains a pressing and exciting avenue of 
exploration. Ultimately, because information can be stored in the brain for years, yet 
AMPARs are highly dynamic with a half-life of only a few days, how can AMPARs be so 
essential in determining synaptic strength that is maintained over days, months and 
years?  
NMDA receptors 
N-methyl-D-aspartate receptors, or NMDARs, are also ligand-gated ion channels 
that are expressed throughout the brain in a spatially and temporally controlled fashion. 
NMDARs play key roles in development and into adulthood in plasticity-related 
processes. NMDARs form the functional core of the synapse with  ~20 NMDARs per 
PSD13. Unlike AMPARs that are highly variable in number from spine to spine, the 
number of NMDARs is fairly consistent across synapses and is very stable over time13. 
The NMDAR is named for (glutamate site partial) agonist N-methyl-D-aspartate, which 
selectively binds to NMDARs and not other glutamate receptors. NMDARs are 
heterotetramers, formed with two GluN1 subunits and two variable subunits, either 
GluN2 or GluN315,96. NMDAR subunits are subject to alternative splicing and result in 
multiple variants; Grin1 encodes for 8 variants of the GluN1 subunit and individual 




must be co-activated by glutamate at the GluN2 subunits and glycine at the GluN1 or 3 
subunits simultaneously15. GluN1 subunits are expressed throughout the brain in 
various cell types. GluN2 subunits are more regulated in expression patterns; individual 
GluN2 subunits are differentially expressed across brain regions and contribute to 
differences in NMDAR channel properties. GluN2A and GluN2B subunits are expressed 
in the hippocampus and have different temporal expression patterns. For example, 
GluN2B expression is high early development and decreases over the first few weeks 
postnatally while GluN2A levels begin to increase at this time. The particular subunit 
composition of the channel determines the biophysical properties of the NMDAR, 
including desensitization and Ca2+-conductance15. 
Each GluN2 subunit has a variable CTD that interact with different intracellular 
effectors, much as described above for AMPAR subunit CTDs. AMPARs are purely ion 
gated but can act as “gatekeepers” or aid in coincidence detection of NMDARs by 
allowing passage of cations into the cell. NMDARs are not only ion-gated like AMPARs, 
but are also voltage-gated by virtue of the depolarization requirement (as carried out by 
entry of cations through the AMPARs) in order to expel the Mg2+-ion block and open the 
channel. As a result of this Mg2+ pore block, NMDARs are not responsible for much of 
the current at the resting membrane potential of -70 mV. Once the channel is activated, 
nonselective passage of cations is allowed, mostly Na+, a small amount of Ca2+ in and 
K+ flow out. While NMDAR Ca2+ -current makes up only a small percentage of the 





There are 100 billion neurons in the brain forming thousands of synapses each. 
One key feature of synapses is their remarkable ability to change strength and structure 
in response to activity. Experience can modify these connections in vivo, strengthening 
some synapses while weakening others. The capacity for hippocampal synapses to 
change their properties post-synaptically is largely due to protein dynamics in and out of 
the PSD. It is this ability to alter synaptic strength that is thought to underlie the ability to 
learn and remember. The faculty to change structure and function of synapses has 
been termed synaptic plasticity. Therefore, identifying the molecular basis of synaptic 
plasticity could provide the foundation to understanding learning and memory. 
Long-Term Potentiation (LTP)  
History of LTP in the hippocampus 
In the late 1800’s Santiago Ramon y Cajal hypothesized that learning could 
result from modulations in synaptic connectivity. Hebb’s famous and recited theory 
stating neurons that wire together fire together was proposed in 1949, again positing 
that connectivity and activity of neurons provides a neural mechanism of memory 
storage97. Synaptic plasticity as we know it was not demonstrated until almost twenty 
years after Hebb’s theory and over a century after Ramon y Cajal98. Synaptic plasticity 
within the hippocampus was first established98 by delivering electrical stimulation to the 
perforant path, which contains axons that synapse onto dentate granule cells. Bliss and 
Lømo observed a sustained increase in the evoked response within the cells of the DG 
that persisted for days. This increased, or potentiated, response due to an 




synaptic response was termed long-term potentiation (LTP). After these seminal 
studies, it has become widely accepted that LTP is the primary mechanism for synaptic 
plasticity and is the cellular correlate of learning and memory.  
Through extensive study, it was determined that LTP occurs at excitatory 
synapses across many different brain regions. However, the classic LTP circuit most 
commonly studied is from the Schaffer collaterals (SC) to CA1 region in the 
hippocampus (Fig 1.1). It was determined that this Hebbian LTP had important facets 
including synapse specificity, cooperativity and associativity3. LTP is only induced at 
synapses that are stimulated with nearby synapses not potentiated, leading to synapse 
specificity. LTP can only be induced with converging inputs to create a depolarization in 
the cell large enough to produce potentiation, causing LTP to be cooperative. And LTP 
is associative because inputs that were too weak to produce potentiation alone can be 
paired with strong inputs to induce potentiation3.  
There is strong evidence to support changes in the post-synaptic cell as 
conferring LTP99, despite early debate as to whether LTP was a pre- or post-synaptic 
phenomenon. LTP results from activation of post-synaptic receptors by pre-synaptic 
glutamate leading to strong post-synaptic depolarization. During LTP induction, 
AMPARs are activated and relieve NMDAR pore blockade by Mg2+ to permit Ca2+ entry 
into the post-synaptic cell, increasing post-synaptic Ca2+ concentrations and initiating 
changes in synaptic strengthening99,100. The post-synaptic mechanisms of LTP require 
downstream signaling cascades initiated by NMDAR Ca2+, such as kinase signaling of 
CaMKII, PKA, and PKC. For example, CaMKII is necessary and sufficient for LTP 




complex changes in AMPARs, such as change in number (via endo- and exocytosis or 
lateral diffusion), subunit composition, protein-protein interactions and/or 
phosphorylation state to influence channel localization and biophysical 
properties20,99,101,102. Each of these processes is governed by a number of proteins that 
alter AMPAR trafficking and scaffolding at the synapse. The result of enhanced post-
synaptic response to glutamate is increased AMPAR-mediated transmission and long-
lasting potentiation. 
Calcium-permeable AMPARs and LTP 
It has long been appreciated that NMDARs are required for induction of LTP (the 
NMDAR competitive antagonist AP5/V blocks induction of LTP in hippocampal slices) 
and that the Ca2+ they provide is an important signal for LTP, but more recent 
studies36,103,104 have implicated another Ca2+ source, the CP-AMPAR. Though 
pyramidal cells in the mature hippocampus highly express GluA2-containing AMPARs 
and basally NMDARs are likely the major source of Ca2+ in dendritic spines, these cells 
can still recruit or express GluA2-lacking receptors under certain conditions36,105-108. 
Early evidence suggested no requirement for AMPARs during LTP induction109,110, 
however considerable research has been dedicated to AMPAR involvement in LTP 
since these early studies. 
The earliest CP-AMPAR literature studied synaptic transmission onto local circuit 
cortical GABAergic interneurons important for precise timing of the excitatory pyramidal 
cell AP firing and coordinating large populations of pyramidal cells. This excitatory 
transmission onto interneurons was classified as having rapid rise and decay times111-




receptors114 that are blocked by polyamines and have high single-channel 
conductance115. A novel form of short-term plasticity was identified in interneurons 
involving short-term facilitation by activation of GluA2-containing receptors116-118 that 
relieves the endogenous polyamine block on GluA1-containing receptors26,119,120, which 
causes a use-dependent increase in current. CP-AMPARs were first implicated in long-
term forms of plasticity at excitatory synapses onto interneurons within the amygdala121; 
it was found that LTD at this synapse was NMDAR-dependent but also requires CP-
AMPARs. 
CP-AMPARs, classified by their increased inward rectification and sensitivity to 
polyamine-derived drugs (such as NASPM, IEM, and PhTx15) are recruited to synapses 
in the hippocampus resulting in an increase in inward rectification after LTP36,104. These 
receptors are incorporated into the synapse and then subsequently removed within ~15 
min of LTP induction36. Blocking CP-AMPARs at early time points after LTP induction 
will prevent LTP, but not after LTP is already established around 30 minutes after 
induction29,36,122,123; this indicates CP-AMPARs are important in a short window 
following induction and that early Ca2+ entry through these receptors is important for 
establishing the expression of LTP but not in maintaining LTP expression once 
established. As mentioned previously, GluA1/2 heteromers have much smaller single 
channel conductance than GluA1 homomers and it has been revealed that >80% of 
synaptic receptors in the hippocampus are GluA1/2 heteromers16 and most GluA1 
homomer expression is limited to immature synapses (>P7) (but see 124, 8-10%). 
GluA2/3 receptors are not thought to be involved in plasticity16,125 (but see126). Because 




reasonably result a significant change in post-synaptic current with only ~5% CP-
AMPAR receptor content needed to account for the increased conductance seen during 
LTP21,127,128, hence the attractive and experimentally supported hypothesis that CP-
AMPARs help to increase post-synaptic currents for a short yet critical period after LTP 
induction. 
Controversy surrounding CP-AMPAR involvement in LTP 
Though multiple lines of investigation suggest that CP-AMPARs are recruited 
during LTP, significant controversy still exists due to other studies showing there is no 
GluA1 homomer involvement125,129. It has become clear over time and with more 
experimental evidence that a number of variables could be contributing to the 
inconsistency of CP-AMPAR involvement in plasticity, including age of animal, and 
induction protocol (Table 1.1). One crucial variable that appears to contribute to the CP-
AMPAR participation in LTP is age of the animals used in the study. The Dell’Acqua 
laboratory and others36,103,104 have shown that at approximately 2 weeks of age there is 
robust recruitment of CP-AMPARs during LTP induction, which disappears between 
P14 and P17 and then reappears >P42. This corresponds with AMPAR subunit 
expression during development where CP-AMPARs are expressed early and then 
exchanged for CI-AMPARs after ~2 weeks130. The baseline expression of receptors 
matters a great deal to the output basally as well as the susceptibility to potentiating 
stimuli, therefore age will highly influence the underlying mechanisms of plasticity by 
determining the AMPAR milieu at the synapse and altering the plasticity of plasticity 
itself, or so-called meta-plastic state. Another variable contributing to receptor 




exist many types of plasticity in vivo81, but also within the literature there exist many 
diverse protocols to induce LTP ex vivo in slices whether using extracellular field 
recordings or whole-cell voltage and current clamp recording. The inconsistency in 
induction protocol plays a pivotal role in the signaling pathways initiated and then 
probed for, including the mechanisms that recruit CP-AMPARs. A further conundrum 
exists whereby studies in the past (and even ongoing studies) have tried to understand 
AMPAR involvement in plasticity by manipulating the receptor. But there are clear 
problems with the “receptor-centric” approach to understanding AMPAR subunit 
contributions. Often AMPARs are used to measure synaptic transmission, however, 
when manipulations are made to the receptor itself it can complicate interpretations as 
the manipulation could affect receptor function and therefore the experimental readout. 
Whole receptor or subunit knockouts are further complicated due to compensation by 
other receptors or subunits, potentially forming non-physiological receptors and 
conditions. Therefore, while there is strong evidence to suggest the involvement of CP- 
AMPARs in some types of plasticity, there still remains controversy and questions about 
the precise forms of plasticity and signaling mechanisms. 
LTP mechanisms: AMPAR recruitment hypotheses 
AMPAR insertion models: trafficking and lateral diffusion 
Despite the controversy of the involvement of CP-AMPARs in plasticity, it is 
widely accepted that AMPARs are recruited to the synapse in order to increase synaptic 
strength. A number of non-mutually exclusive hypotheses exist to explain how AMPARs 





Table 1.1 CP-AMPAR plasticity studies  
 
 
Paper Age/Species LTP Induction Protocol CP-AMPAR? 
 







Fields: 2 x 100 Hz, 10 
s interval; Whole-cell: 2 
Hz, 100 pulses paired -
10 mV holding; current 
clamp recordings 
All were insensitive to 100-
200 µM IEM1460 
 





Fields: 4 x 100 Hz, 20 
s interval; Whole-cell: 2 
Hz, 60 s paired 
between -10 – 0mV 
All insensitive to 10 µM 
PhTx-433 
 
Granger et al. 2013125 
P17-20 
mouse 
Whole-cell: 2 Hz, 90 
sec at 0 mV 
Gria1-3
fl/fl; rescued with 
mutant receptors (all were 
Ca2+ permeable). No 
AMPAR subunit important 
for LTP. 
 
Plant et al. 200636  
 
2-3 weeks  
Mouse 
Whole-cell: 0.5 – 2 Hz, 
50 – 100 pulses paired 
to 0 or -10 mV 
Rectification changes for 
~15 min post-induction; 
sensitive to 10 µM PhTx-433 
 
Guire et al. 2008128  
 
4-6 weeks  
Rat 
Fields: TBS (4 x 100 
Hz, 5 trains at 5 Hz) or 
HFS (3 x 100 Hz, 20 s 
interval) 
TBS stim (not HFS) sensitive 
to 30 µM IEM1460 
immediately after induction 
(not 20 min later) 
 







Fields: 2 x 100 Hz, 20 
s interval 
2 week old sensitive to 2.5 
µM PhTx and 20 µM 
NASPM 
3,4,8 week old insensitive 
 




Fields: TBS (3 bursts 
of 5 Hz, 5 pulses 100 
Hz 2x, 20 s interval) 
Incomplete expression of 
LTP with 10 µM PhTx-433, 
Ca2+ entry from CP-AMPARs 
required for LTP 
 




Fields: 1 x 100 Hz, 1 s 2 week old 70 µM IEM1460 
sensitive,  
3 week old insensitive  
 




cTBS 3 TBS episodes, 
10 s interval, sTBS 3 
TBS episodes, 2 min-1 
hr interval 
wTBS 1 TBS episode 
wTBS,cTBS insensitive to 30 
µM IEM1460 
sTBS sensitive  to 30 µM 
IEM1460 
 




Whole-cell: LTP 1x100 
Hz, 4x100 Hz; Fields: 
100 Hz, 1 s 1 or 4 times 
with inter-train interval 
of 10 s or 5 min 
LTP depends on GluA1 C-
terminal tail; did not address 
CP-AMPARs but based on 





AMPAR insertion model, which includes AMPAR trafficking and lateral 
diffusion41,51,87,134. Dogma at the neuromuscular junction (NMJ) suggested that post-
synaptic acetylcholine receptors were quite stable and minimally regulated135. However, 
it was observed that synapses in the CNS vary in AMPAR content136-139 and it was 
found later that AMPAR trafficking is dynamic and can be modified by neuronal activity. 
One proposed mechanism for AMPARs delivery to the synapse is through exocytosis 
from internal stores. A seminal contribution to elucidating plasticity related mechanisms 
was that dynamic membrane trafficking is required for expression of LTP and 
LTD69,140,141.  
Most models of LTP include a significant pool of surface receptors needed for 
LTP expression101,125,142. An additional pool of receptors could reside in internal stores 
to be recruited or replenished during activity. One prominent pool of internal AMPARs is 
the recycling endosome (RE). REs have been observed in dendritic spines143,144 and 
bases of spines145. To support the idea of receptor delivery from internal vesicle pools, 
the fusion machinery requisite for exocytosis is required for LTP expression146-149. 
NMDAR activity can influence RE pools148, such as after LTP, which increases recycling 
and promotes RE translocation into spines148,149. However, blocking post-synaptic 
exocytosis acutely does not affect basal transmission, although chronic blockade will 
eventually lead to run-down, hinting that there may be two pathways for AMPAR 
membrane delivery: constitutive (such as for the GluA2-containing 
receptors/heteromers) and activity-dependent (which could largely include GluA2-
lacking receptors/GluA1 homomers). This model, implicating two AMPAR pathways, 




trafficked to the cell surface. Multiple lines of evidence suggest that during activity 
GluA2-lacking receptors are recruited and then replaced with GluA2-containing 
receptors after activity to maintain AMPAR number and activity-state20,36,150,151. PICK1 
associates with GluA2 and seems to be involved in the regulated recycling/endocytosis 
of GluA2-containing receptors during LTP and promoting GluA1 insertion123. GRIP1 
anchors AMPARs at synapses64 and NSF helps regulated the constitutive cycling of 
GluA2-containing AMPARs72. It has also been demonstrated that LTP relies on receptor 
recycling134. These studies support the hypothesis that AMPARs need to be exchanged 
in and out of the synapse from internal stores both basally and during activity to 
maintain proper synaptic strength. 
Another hypothesis of how AMPARs are dynamically regulated at the synapse is 
through AMPAR lateral diffusion. As previously mentioned, AMPARs are mobile within 
the PM89,101, with extrasynaptic receptors exhibiting high mobility. The extrasynaptic 
receptor population can enter the synapse, which subsequently decreases their 
mobility152. Some believe that AMPARs are only recruited from a large surface pool of 
receptors during plasticity to account for the need of receptors to increase synaptic 
strength153,154. It appears that this mechanism of receptor recruitment is not the only 
mechanism for receptor recruitment given the evidence above regarding AMPAR 
mobilization from internal stores, indicating cooperation between different mechanisms 
of receptor recruitment. In fact, in a recent paper155, the Choquet laboratory showed that 
blocking lateral mobility of AMPARs blocks early LTP, but only when lateral mobility and 
exocytosis from internal stores is blocked will both induction and maintenance of LTP be 




AMPAR synaptic recruitment by means of phosphorylation 
Whether AMPARs are recruited to the synapse from internal stores or through 
lateral diffusion, there still exists the fundamental question of what signal mobilizes them 
to the synapse? One hypothesis to explain receptor recruitment is AMPAR 
phosphorylation or modification. In the late 1980’s, it was demonstrated that kinase 
activity was required for induction of LTP156-158. This led to a hypothesis that AMPAR 
subunits were phosphorylated during LTP leading to the regulation of the receptor and 
an increase in synaptic currents159,160. Since then, studies of activity-dependent AMPAR 
phosphorylation have focused on modification of GluA1 and GluA2 subunits, as the 
sites on these subunits were shown to be regulated by neuronal activity20,60. Strong 
evidence supporting the importance of phosphorylation control of AMPARs in plasticity 
was shown in the late 1990s, with increased phosphorylation correlated with LTP and 
decreased with LTD161-164. GluA1 phosphorylation at S831 by CaMKII and/or PKC has 
been shown to increase channel conductance from 12 pS to 20 pS165. PKA-dependent 
phosphorylation of S845 promotes insertion of the receptor, especially 
extrasynaptically122,166-169, and is required for LTP170.  
To study the subunit specific requirements of LTP, many labs have used a 
knockout, knock-in or molecular replacement approach. It is not surprising that, as in 
much of the AMPAR literature, the significance of subunit specificity of plasticity is 
contentious. No C-terminal tail manipulation that blocks phosphorylation of the AMPAR 
CTD residues completely blocks LTP. LTP is still present in double mutant 
S831/845A171, with the single point mutants showing normal LTP172, and there is normal 




GluA1 PDZ interactions are not required for LTP88,173, but can act in a modulatory 
role174. Nevertheless, a reproducible result is that knocking out GluA1 results in 
impaired AMPAR surface expression and LTP125,175, but GluA2 and GluA3 knockouts 
have normal LTP176. Interestingly, a recent study133 examining the requirement of the C-
terminal tails of GluA1 and GluA2, showed that loss of GluA1 C-terminal tail blocks LTP 
but it can be rescued by reintroducing only the GluA1 CTD and even by swapping the 
CTD of GluA2 with the CTD of GluA1. This study firmly established the GluA1 CTD as 
essential for AMPAR trafficking and LTP expression. These studies use varying 
protocols for inducing LTP and study subunit CTDs using non-physiological conditions, 
which could contribute to discrepancies in conclusions (Fig 1.4, Table 1.2). 
Nonetheless, AMPAR phosphorylation appears to play a crucial role in receptor function 
and localization and a complicated role in LTP. 
AMPAR organization within the synapse during LTP. 
Once at the synapse, AMPARs are organized within and around the PSD78,79. 
There are around 5 times more PSD-95 molecules than AMPAR molecules in the 
synapse13 so it appears unlikely that recruiting more PSD-95 itself could account for 
increased AMPAR retention during LTP. During LTP, hearkening back to the idea of 
modular synaptic composition, the addition of AMPARs to silent modules (i.e. synapses 
lacking AMPARs) is thought to underlie increased transmission instead of adding 
receptors to already functional AMPAR modules81. Early LTP seems to depend on an 
increase in quantal response and later LTP depends on increase in quantal content, 





Table 1.2 AMPAR studies in transgenic mice 
Paper(s) Mutation Age Result 
 









Unaffected: Basal localization and 
transmission, LTP (fields: 1 TBS, whole-cell 
pairing: 2 Hz, 200 pulses at 0 mV) and LTD 
(Fields: 1 Hz, 900 pulses, whole-cell pairing: 
0.5 – 1 Hz, 200 – 300 pulses at -40 mV) 
 









P17-20 No single portion of the GluA1 C-terminal tail is 
required for LTP (2 Hz, 90 sec at 0 mV), GluA2, 
GluA2(Q) or GluK1 replacement sufficient to 
rescue LTP 
GluA1 and GluA2 conditional knockouts have 
normal LTD (1 Hz, 15 min), GluK1 replacement 
in GluA1-3 conditional knockout sufficient to 
rescue LTD 
 
Zamanillo et al.  
1999175  
Jensen et al. 2003179  
Hoffman et al. 2002180  












LTP (Fields: 1x100 Hz, 1 s): impaired; normal 
spatial learning (Morris Water Maze) 
LTP: (Fields 1x100 Hz, 1 s/Whole-cell 0.67 Hz, 
3 min at 0 mV)- modest/normal amount of LTP 
at P14 disappears by P42 
LTP: TBS- decreased initially but normalizes to 
WT after 25 min 
Normal spatial memory; spatial working 
memory deficits 
 
Jia et al. 1996182  
Gerlai et al 1998183  














LTP: (Fields 5 x 100 Hz, 200 ms pulses) 
enhanced 
growth retardation and motor deficits, normal 
brain anatomy, increased excitability, 
alterations in a number of behaviors across 
multiple brain areas 
Normal LTD Fields (1 Hz, 15 min); normal  
Depotentiation (HFS 100 Hz 1 sec followed by 
LFS 1 Hz, 15 min); impaired depotentiation but 
enhanced LTP (100 Hz, 1 sec) in adults 
 









Normal basal transmission and pre-synaptic 
function 
Normal LTD (1 Hz, 15 min) 12-16 days 
Normal depotentiation 2-3 weeks 
Enhanced LTP (100 Hz, 1 sec) adults and 
enhanced level of LTP saturation (6 trains of 







Table 1.2 cont’d    
Paper(s) Mutation Age Result 
Meng et al 2003176  GluA2/3 2-3 Reduced basal transmission in adults  











Normal basal transmission 
 
LTP: old (TBS fields) mostly blocked, young 
(TBS fields) normal 
 
LTD: (Fields PP 1 Hz, 15 min) blocked; young 
animals lack LTD as well (1 Hz 15 min); lack 
receptor internalization 
 
MWM: learning normal, impaired retention of 
spatial memory (delayed sessions) 
 









Normal basal transmission 
LTP: 4xTBS fields normal 




Normal basal transmission 
LTP: 4xTBS and 1xTBS fields normal 
LTD: PP-1 Hz fields normal 
Normal de-potentiation and de-depression 
 









Normal basal transmission 
LTP: 4xTBS fields normal 
LTD: 1Hz fields virtually absent 
 
Old- 
Normal basal transmission 
LTP: 4xTBS and 1xTBS fields normal 
LTD: PP-1 Hz fields mostly blocked  
Normal de-potentiation  
 













Both show normal basal transmission 
GluA1-C2KI has normal NMDAR LTD, impaired 
LTP (1x100 Hz, 4x100 Hz) 
GluA2-C1KI has normal mGluR LTD (100 µM 
(RS)-3,5-DHPG for 10 min), not NMDAR LTD 
(900 pulses at 1 Hz), enhanced LTP (4x100 Hz) 
Double replacement: normal everything 
Behavior: GluA1-C2KI impaired spatial learning 





AMPARs modules. It follows then that receptor number alone does not determine 
strength of post-synaptic transmission and still concentration of glutamate also matters 
for receptor activation. Recent work recruiting AMPARs to the synapse from the 
Kennedy laboratory showed that only synapses opposed to a release site could be 
strengthened by recruited receptors184, indicating the necessity for specificity and 
activity-dependence for plasticity-relevant receptor recruitment.  
Another way to explain how AMPARs are recruited to particular synapses is 
through the PSD slots hypothesis154,185-190. In the PSD slot model, CaMKII acts on PSD 
to create receptor slots, which can trap the highly mobile AMPARs in the synapse (due 
to diffusional trapping during plasticity89,173 or increasing AMPAR retention in the 
synapse during LTP by increasing the affinity of AMPARs for the underlying synaptic 
architecture191,192). Incorporated into this idea of slots is that structural rearrangement 
must occur within the PSD to accommodate for additional receptors during potentiation. 
Another iteration of this theory is that slots exist in the PSD but cannot themselves trap 
receptors. This model suggests that receptors are targeted to the PSD through 
phosphorylation (CTD would play a mandatory role) and then those receptors are 
captured once already at the PSD (PSD interacting proteins would be essential as well).  
None of these hypotheses as stated in this section can account for all the 
observations of AMPAR recruitment during LTP. However, the recurrent themes from 
these hypotheses are that AMPARs of specific subunit composition must be available to 
be mobilized to the synapse during LTP and must be retained there for some amount of 




Other LTP phenomena: structural plasticity and LTP in vivo 
Structural plasticity 
 In order to accommodate or support the new proteins delivered or stabilized at 
the synapse, it has been observed that physical spine size increases after LTP. This 
occurrence detected in the later stages of LTP is called structural plasticity. This 
includes delivery of membrane, increased adhesion molecule involvement and 
cytoskeletal remodeling or reinforcement. The resulting change is an enlargement of 
existing spines that lasts for hours193. This thesis will focus more on the molecular 
changes and signaling processes that occur during plasticity; however, these structural 
changes are also occurring but will not be explicitly studied here.  
LTP correlates to learning and memory in vivo 
Potentiation has historically been studied using exogenous stimulation by 
electrodes that activate many axons outside the realm of physiological, naturally 
occurring input. Further, whole-cell pairing protocols often match this pre-synaptic 
stimulation with post-synaptic depolarization. It is no wonder that NMDAR-dependent 
plasticity mechanisms studied in acute slice preparations with less than physiological 
stimuli have been difficult to fully recapitulate or discover in natural behaviors in 
animals. However, in vivo learning and memory mechanisms appear to at least overlap 
with the mechanisms identified ex vivo, providing relevant and important information 
about learning and memory. Through early behavioral experiments, it was found that 
hippocampal-dependent spatial memory has a parallel requirement for NMDAR 
activation as in LTP in acute slices; NMDAR antagonists applied before a learning task 




LTP, such as involvement in baseline neuronal transmission. Confusingly, genetic 
manipulations that disrupt hippocampal LTP can still have intact hippocampal-
dependent learning and memory (such as in 175) and manipulations that keep LTP intact 
can impair spatial learning (for example, 195). Work in the perforant pathway to DG in 
rats demonstrated that saturating LTP as applied by bipolar electrode stimulation could 
occlude memory formation as tested by Morris Water Maze (MWM) performance196. 
Similarly, LTP induced inhibitory avoidance learning in animals can occlude subsequent 
LTP compared to untrained animals197. This study demonstrated not only that LTP is 
likely occurring during behavior but also that it likely acts in the same way as HFS-
induced LTP. There have been similar findings in other brain areas (such as in the 
amygdala with fear conditioning198). Recent work out of the Malinow laboratory199 
revealed the interplay between LTP and LTD in vivo, using optogenetics to either elicit 
LTD-stimuli to inactivate or LTP to reactivate fear memories.  
As for the direct involvement of AMPAR-mediated mechanisms of LTP in vivo, 
Takemoto et al. showed that inactivation of synaptic AMPARs through chromophore-
assisted light inactivation (CALI) erased fear memories200. Of note, CP-AMPAR 
trafficking has been identified as important in whisker response in the neocortex105. Fear 
conditioning requires phosphorylation of S845 and promotes synaptic recruitment of 
CP-AMPARs in the amygdala while fear extinction requires CP-AMPAR removal201,202. 
Within the addiction and drug use literature, cocaine has been found to increase CP-
AMPAR insertion in the Ventral tegmental area (VTA)203-205. Though most of this work is 
highly correlative, taken together, these studies suggest strong physiological relevance 




Long Term Depression (LTD) 
Twenty years after the discovery of LTP in the hippocampus98 and ten years after 
the finding that LTP initiation requires NMDAR activation206, LTD within the circuit was 
discovered207. In contrast to LTP induced by brief, high frequency stimulation, LTD 
induction results in a smaller response to the same test stimulus after low frequency 
stimulation for longer periods of time (minutes rather than seconds in LTP). There are 
many different forms of LTD including homosynaptic, heterosynaptic, de novo, or de-
potentiation following LTP208. In addition, there are multiple protocols for experimentally 
inducing LTD, like low frequency stimulation (LFS), spike timing dependent plasticity 
(STDP) and chemical LTD (cLTD). Apart from NMDAR-dependent LTD, another 
mechanism for LTD induction is through an mGluR-dependent pathway. This mGluR-
LTD is usually induced with similar activation patterns as NMDAR-LTD, however 
mGluR-LTD can be induced using paired-pulse LFS209 and the group I mGluR agonist 
dihydroxyphenylglycine (DHPG)210. This mGluR-dependent form of LTD will not be 
further discussed in this thesis, and any use of LTD hereafter will be referring to 
NMDAR-dependent LTD. 
NMDAR-dependent LTD requires post-synaptic Ca2+ influx and phosphatase 
activity supported by evidence that LTD expression is blocked by BAPTA (Ca2+ 
chelation)211 and calcineurin (CaN) inhibition212. Depotentiation and de novo LTD rely on 
NMDAR activation and downstream signaling207. This is paradoxical because LTP also 
requires NMDAR activation. Like LTP, NMDAR-LTD alters post-synaptic receptor 
content, but unlike LTP, LTD results in a decreased response to pre-synaptic glutamate 




conductance213. One way to explain different outcomes from the same Ca2+ source 
could be that higher Ca2+ is needed to activate low-affinity kinases, but lower Ca2+ 
activates higher-affinity phosphatases. In fact, low-level Ca2+ from NMDARs initiates 
phosphatase signaling through protein phosphatase 1 (PP1) and CaN214-216.  
 Among the targets of phosphatases, AMPARs are dephosphorylated at S845 
during LTD by CaN and PP1, which promotes receptor endocytosis and is required for 
LTD104,163,171,172. Endocytic zones have been discovered at the periphery of excitatory 
synapses217 and these zones are the sites of clathrin-coated pit formation218 and 
AMPAR internalization219. Using a cLTD treatment162, it was discovered that there is 
rapid AMPAR endocytosis220-223, and then AMPARs are sorted in endosomes for either 
recycling or degradation. It was also observed that there is decreased synaptic AMPAR 
content with in vivo LTD induction224. For NMDAR-dependent AMPAR internalization 
(like LTD) Ca2+ influx and activation of CaN is needed220,223,225. Interestingly, our 
laboratory recently identified the transient incorporation of CP-AMPARs during LTD 
induction and then subsequent removal within 5 minutes of induction104. This is similar 
to LTP in young animals however the time-scale is different (removal within ~15 min of 
LTP induction) and provides an additional link of the CP-AMPAR to plasticity 
mechanisms. 
Though it is widely accepted that AMPARs are removed during LTD, there is no 
coherent model of the removal of AMPARs during LTD. The CTD of GluA2 is a 
phosphorylated at Serine 880, disrupting scaffolding interactions with its PDZ ligands to 
block LTD226,227. To support this idea of receptor phosphorylation occurring in LTD, 




5 (CDK5), p38 Mitogen-Activated Kinase (MAPK), and Glycogen Synthase Kinase 
(GSK3) have all been implicated in LTD208. Additionally, studies show that the 
GRIP/ABP-GluA2/3 interaction is required for LTD228 and the PICK-GluA2 interaction 
during LTD is regulated by Serine 880 phosphorylation. However, both GluA2 and 
GluA2/3 double knockout retain LTD176. But, LTD is deficient in S845 to Alanine 
(S845A) GluA1 mutant172, but LTD is normal in mice lacking GluA1 subunit229. 
Therefore the mechanisms of AMPAR removal during LTD are still a bit ambiguous in 
the hippocampus.  
Additional LTD happenings: structural plasticity and LTD in vivo 
Structural LTD, as mentioned above concerning LTP, also occurs in hippocampal 
neurons resulting in spine shrinkage or elimination and actin remodeling. Also as 
mentioned above, this will not be the focus of the research explained further in this 
thesis. 
De novo NMDAR-dependent LTD is easily expressed early in development but 
becomes more difficult to induce in adult brains230,231 or in vivo232-234. LTP and synaptic 
potentiation have been shown to be involved in learning and memory in vivo, however 
the role of LTD in vivo has yet to be firmly established due to the inability to specifically 
block LTD with pharmacology or protein disruption because of the overlap in 
mechanism with LTP. There is mixed and varied evidence for LTD in vivo but limited 
examples include: in the hippocampus correlating with learning and memory such as 
behavioral flexibility and novelty, the amygdala with fear extinction, and other brain 
areas (amygdala, perirhinal cortex, VTA, and nucleus accumbens)208.The best evidence 




experiments, such as during monocular deprivation, demonstrating that LTD is 
important in the developing visual system208. Monocular deprivation can induce LTD at 
thalamo-cortical inputs in visual cortex to decrease visual responsiveness to the 
deprived eye235,236. But this LTD is developmentally regulated and is more difficult to 
induce in adults, as mentioned previously236. Some compelling evidence that LTD (and 
LTP) are involved in behavior was in the amygdala using optogenetic stimulation; fear 
conditioning could either be inactivated by LTD stimulation or reactivated by LTP 
stimulation199. Intriguingly, if the memory was inactivated by LTD, it could be reactivated 
by LTP stimulation of the pathway. By mimicking HFS stimulation using optogenetics, 
this study shows a clear relationship between LTP- and LTD-like stimuli and behavioral 
output. Despite having less robust experimental evidence than LTP, LTD appears to 
play an important role in a number of processes and behaviors in vivo. 
Plasticity and learning and memory in disease 
 Plasticity has long been studied to gain a better understanding of learning and 
memory with the ultimate goal of identifying the fundamental and basic processes 
underlying human cognitive function. Beyond this goal of understanding how a typical 
brain orchestrates these essential functions, there is a great need to understand what 
happens to these processes during abnormal brain states or diseases. Pathological 
synapse development and/or function has been implicated in neuropsychiatric disorders 
(schizophrenia, autism, intellectual disability (ID)), neurodegeneration (Alzheimer’s 
Disease (AD)) and following stroke13. Some of the molecules implicated in plasticity 
could be involved in neuropsychiatric and neurodegenerative disorders237,238. As an 




with AMPAR regulation have been linked to multiple nervous system diseases (AD, 
ischemia, epilepsy, traumatic brain injury, Amyotrophic lateral sclerosis, among 
others)239. Consequently, understanding synaptic function and plasticity at the molecular 
and cellular level is fundamentally important and has clear clinical implications. 
A-kinase anchoring proteins 
It is ever so intriguing that the vast number of signaling molecules within the 
immense, convoluted volume of a neuron can signal in a specific or activity-dependent 
manner. What has become appreciated through years of study is that a number of 
signaling molecules are not just randomly drifting through the cytoplasm, but can 
instead be scaffolded near their sites of action. One such scaffolding molecule that 
plays an essential role in neuronal activity-coupled signaling is A-kinase anchoring 
protein (AKAP) 79/150. AKAPs are defined by their ability to bind the cAMP-dependent 
protein kinase A (PKA); all AKAPs have a canonical amphipathic α-helix, which acts as 
a docking site for the regulatory subunit of PKA. Regulatory subunit composition 
determines sensitivity to cAMP (Regulatory subunit I > Regulatory subunit II) and 
selectivity of AKAP interactions (some AKAPs preferring RII over RI and vice versa). 
PKA is a Serine/Threonine kinase that forms a heterotetrameric holoenzyme 
composed of two catalytic (Cα or Cβ) and two regulatory (RIα, RIβ, RIIα or RIIβ) 
subunits. A flexible linker between AKAP anchoring and the cAMP binding C-subunit of 
PKA allows for PKA to adopt a number of conformations, allowing for cAMP-
independent PKA activity under basal conditions240,241. Recent work showed that the 
activity range of anchored PKA could be restricted to 150-250 Å of the PKA-AKAP 




family of proteins, it is a large family with differential expression across multiple cell 
types and tissues and participation in varied cellular processes. In fact, a number of the 
AKAP family members are also multivalent scaffolds, anchoring additional signaling 
enzymes and effector proteins throughout assorted subcellular compartments (such as 
AKAP79/150 anchoring both PKA and CaN on the same AKAP molecule243. This thesis 
will hone in on AKAP79/150 (also called AKAP5).  
AKAP79/150 
AKAP79 (human)/150 (rodent) encoded by the AKAP5 gene is highly enriched in 
brain, found within the hippocampus at the excitatory post-synapse103,244-246, recycling 
endosomes247,248, and in dendrites249. It has also been found in superior cervical 
ganglion250,251, dorsal root ganglion at the somatic PM252, the nucleus accumbens in 
medium spiny neurons at the excitatory post-synapse253, and in the ventral tegmental 
area within dopamine neurons at the inhibitory post-synapse254. AKAP79/150 is known 
to bind the kinase PKA244,255 at the distal C-terminus of the scaffold using the 
aforementioned canonical amphipathic α-helix. It also can bind the Ca2+-CaM-
dependent phosphatase CaN243,246,256-258 through the CaN-A subunit binding to a PxIxIT 
motif located just N-terminal to the PKA binding site (Fig 1.5A). This is particularly 
important when considering the synaptic signaling that requires bidirectional PKA and 
CaN signaling, like controlling the phosphorylation state of AMPARs during plasticity. 
AKAP79/150 also can anchor PKC259,260, which is activated by Ca2+ and diacylglycerol 
(DAG), at the N-terminus of AKAP with a pseudo-substrate like motif and competes with 
binding of Ca2+-Calmodulin that is by nature tightly coupled to changes in intracellular 




The N-terminus of the AKAP79/150 protein participates in many different cellular 
activities245,249,259,262,263, including interacting with the PM. Immunocytochemistry for 
AKAP150 protein in hippocampal neurons shows a clear association with the somato-
dendritic plasma membrane but notably enrichment in dendritic spines. Which begs the 
question: how is AKAP79/150 itself targeted? Previous studies showed that within the 
N-terminus exist three membrane targeting polybasic domains (A, B, and C), two of 
which also contain conserved palmitoylation sites247,248,264,265. AKAP79/150 can interact 
with the membrane through electrostatic interactions of the three polybasic domains 
with the acidic phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2). AKAP79/150 
can also bind N-cadherin (a neuronal CAM), and the actin cytoskeleton (F-actin) via 
these domains245,256,262. AKAP79/150 can be further targeted to post-synaptic glutamate 
receptor signaling complexes through its internal MAGUK binding domain266-268. The 
MAGUK family of proteins, specifically PSD-95 and SAP97267,269, can interact with 
AKAP79/150 by way of their C-terminal SH3 and GK domains and these interactions 
allow assembly of large signaling complexes by bringing the AKAP near scaffolded 
substrates such as the AMPAR and NMDAR267. Of note, but not to be focused on 
further, AKAP79/150 can also associate with adenylyl cyclase (AC)270,271, the L-type 
Ca2+ channel (LTCC) through a modified leucine zipper (LZ) at the extreme C-
terminus257, TRPV1252,272, potassium channels Kv7.2/3
250 and Kv4.2
273, and the β2-
adrenergic receptor (β2-AR)274. 
It has been estimated that there are ~20 AKAP79/150 molecules per synapse53 
positioned near and acting on AMPARs. This emphasizes the connection during 




and biophysical properties of receptors, controlled by kinase and phosphatase mediated 
phosphorylation and dephosphorylation. Accordingly, AKAP-anchored PKA and CaN 
are important in regulating synaptic AMPAR content104,269,275. The first evidence of 
AKAP-anchored PKA influencing AMPAR-mediated transmission came from 
pharmacological studies utilizing a peptide Ht31 that interferes with AKAP-PKA 
binding255, revealing that blocking this interaction resulted in decreased AMPAR 
currents276. Later studies found that AKAP79/150 is the primary AKAP targeting PKA to 
post-synaptic spines256,277,278. AKAP79/150 interacts indirectly with AMPARs via 
SAP97266,267,277 to couple synaptic activity with PKA-dependent phosphorylation of S845 
on GluA1166,170,279. Other studies have found that AMPARs can be further regulated by 
AKAP-anchored PKC through phosphorylation of S831263. During LTP and LTD, AKAP 
can help facilitate AMPAR addition and/or removal via its complex with 
AMPA/PKA/CaN104,275. Further, it has been demonstrated that AKAP-anchored CaN is 
required for LTD280 and AMPAR endocytosis266. In line with their clear importance in 
controlling neuronal functions, AKAP79/150 and other AKAPs have been implicated in 
diseases such as seizures, addiction, pain, and neurodegeneration like AD and 
Parkinson’s disease253. 
AKAP79/150 mutation studies 
To understand AKAP79/150 function, our laboratory and others have taken to 
transgenic mouse models to study the effects of manipulating AKAP anchoring at the 
synapse. As explained below, the AKAP150 total knockout showed surprisingly mild 
phenotypes given the deletion of such an important signaling hub. It is a notable caveat 




transgenic animal. Further, it can be complicated figuring out what particular component 
of the scaffold is responsible for what phenotypic expression due to the multivalent 
capacity of the protein. So to circumvent these issues, the Dell’Acqua laboratory and 
others have studied the importance of AKAP79/150 specific enzyme anchoring in 
hippocampal neurons using overexpression, knockdown/replacement and knock-in 
mutations altering the different enzyme anchoring sites. A summary of the published 
data is listed in (Table 1.3, Fig 1.5B) and detailed below. 
AKAP150 knockout (KO) 
Two separate knockout mouse lines of AKAP150 have been generated281,282. 
The first mutant described281 exhibited a lack of PKA localization to dendritic spines. 
This was accompanied by decreases in GluA1 S845 phosphorylation and AMPA 
agonist-induced current, impaired LTD, and decreased spatial memory retention in the 
MWM hippocampal-dependent behavioral task. These first AKAP150 KO mice also 
showed impairments in various cerebellum-dependent behavioral tasks, as AKAP150 is 
highly expressed in cerebellar neurons. Finally, this knockout showed a decreased 
susceptibility to pilocarpine-induced seizures. 
The second mutant282 had normal LTP and LTD with normal performance in the 
MWM, reversal learning, novel object recognition task and open field test. Similar to the 
first report, PKA is lost from spines and increases association with the dominant 
dendritic PKA scaffold, MAP2. However, the phenotypes in this mutant are for the most 
part mild and largely no different than WT controls. These KO models hint that 
disrupting a multivalent scaffold can have offsetting results, such as by perturbing both 






Figure 1.5: AKAP150 WT and binding-deficient mutants.  
A. WT AKAP150 interacts with and anchors a number of proteins at the post-synapse. 
Namely, AKAP localizes to the membrane through interactions within the polybasic 
domains at the N-terminus of the protein. AKAP anchors the phosphatase CaN and 






AKAP150-PKA binding deficient mutants ΔPKA and D36 
To specifically study AKAP150-PKA uncoupling, specific mutations that perturb 
AKAP-PKA binding through mutating the amphipathic α-helix that PKA binds to on the 
AKAP were generated through a knock-in transgenic mouse model. The D36 AKAP150 
PKA-binding mutant was developed first by truncating the last 36 amino acids of the C-
terminal domain of AKAP. D36 mice were found to have normal basal transmission (in 
2, 4-5 and 7-12 week old animals) and normal basal S845 phosphorylation (at 1, 4 and 
8 weeks) but impaired activity-induced phosphorylation of S845 at 4 weeks103,283. LTP is 
normal in 4-5 week old animals, but impaired at 8 weeks103. LTD is impaired in 2 week 
old animals however depotentiation is normal. These mice also exhibit impairment in the 
reversal-learning phase in an operant conditioning task282.  
The D36 model has a few complications due to the nature of the truncation; the 
mutant removes the C-terminal portion of AKAP resulting in the removal of an important 
interaction domain for the LTCC. To circumvent any issues with deleting the additional 
LZ domain that binds the LTCC104, our laboratory developed the AKAP150-PKA binding 
deficient mutant ΔPKA that just removes 10 amino acids (709-718) from the N-terminal 
portion of the amphipathic α-helix PKA RII binding site. Overall, phenotypes for the D36 
and ΔPKA animals are very similar. ΔPKA animals have normal basal transmission 
(excitatory and inhibitory transmission at 2-3 weeks) but decreased GluA1 S845 
phosphorylation basally. ΔPKA mice show a slight increase in dendritic spine number. 
Similar to D36, ΔPKA animals retain only ~10% of LTD expression. LTP expression is 
normal but insensitive to CP-AMPAR antagonism with IEM1460, unlike WT that is 




AKAP-anchored PKA promotes GluA1 phosphorylation and CP-AMPAR recruitment 
both during LTP and LTD. 
AKAP150-CaN binding deficient mutant ΔPIX 
Similar to D36 and ΔPKA animals, to study decoupling of AKAP150 and CaN, 
our lab generated a mutant mouse model that deletes the 7 amino acids (655-661) 
containing the PIAIIIT PxIxIT domain, which we call ΔPIX. ΔPIX mice have normal spine 
density and basal transmission with enhanced basal GluA1 S845 phosphorylation275. 
Mice with this mutation exhibit impaired NMDAR-dependent LTD and enhanced 100 Hz 
LTP. The mechanism for this appears to be a lack of removal of AMPARs and 
AKAP150 from the PSD following LTD. Further, ΔPIX animals show enhanced CP-
AMPARs basally that act to inhibit LTD and facilitate enhanced LTP. AKAP-anchored 
CaN appears to be important for restricting synaptic incorporation of CP-AMPARs, by 
opposing PKA-mediated phosphorylation of S845, basally and in the removal of 
transiently recruited CP-AMPARs both during LTP and LTD104,275. 
Protein palmitoylation 
Palmitoylation, the dynamic post-translational lipidation 
As mentioned above, AKAP79/150 is targeted to the membrane through a 
number of interactions within the N-terminal domain. In addition to this targeting, 
AKAP79/150 is also post-translationally modified by fatty acids at two sites in the 
targeting domain to facilitate membrane interactions. Besides scaffolding proteins, cells 
have adapted numerous methods to facilitate the precise trafficking and distribution of 
proteins to various specialized compartments. Some of these methods are post-











2 weeks normal or slightly enhanced 
8 weeks normal 
LTP (100 Hz, 1 sec) 
8 weeks normal  
LTD (1 Hz, 15 min) 
2 weeks normal 
8-16 weeks impaired (?) 
Behavior 
Modest deficits spatial memory 
Normal reversal learning 
Impaired cerebellar behaviors 
Reduced pilocarpine seizures 
Tunquist el al. 
2008281  
Weisenhaus 
et al. 2010282  
 
D36 Basal  
Normal  
LTP (100 Hz, 1 sec) 
4-5 weeks normal 
8 weeks impaired 
LTD (1 Hz, 15 min) 
2 weeks impaired (retain ~10%) 
Depotentiation (100 Hz, 1 sec and 5 min 
later 1 Hz, 15 min) 
Normal 
Behavior 
Impaired reversal learning 
Normal spatial learning, working memory, 
and open field behaviors 
Lu et al. 
2007103  
Lu et al. 
2008283  
Weisenhaus 




LTP (100 Hz, 1 sec) 
2 weeks normal magnitude (but not CP-
AMPAR dependent) 
LTD (1 Hz, 15 min) 
2 weeks impaired (retain ~10%) 
Sanderson et 
al. 2016104 
ΔPIX Basal  
Normal but increased CP-AMPARs 
LTP (100 Hz, 1 sec) 
2 weeks enhanced, but 50 Hz, 2 sec normal 
Depotentiation (100 Hz, 1 sec and 30 min 
later 1 Hz, 15 min) 
Impaired: depotentiates to a similar amount 
but does not reach WT baseline levels 
LTD (1 Hz, 15 min) 
2 weeks impaired (1 Hz PP 900 pulses 50 
ms interval LTD and 10 Hz transient 











glycosylation. These modifications allow for activity-dependent changes beyond genetic 
control to facilitate protein trafficking, function, interactions and/or stability. In particular, 
fatty acid modifications increase hydrophobicity of proteins and subsequent insertion 
into intracellular membranes and the PM. It was first discovered that proteins could 
contain covalently bound fatty acids in the late 1970’s284. In the years since, it was 
found that many types of lipidations commonly occur in cells to help maintain ordered 
protein distribution; common lipid modifications include myristoylation, prenylation, and 
palmitoylation. A broad range of lipidations can be added to cysteines and this general 
fatty acid linkage to cysteines is called acylation. Acylation appears to be an abundant 
modification as it is estimated that ~10% of the human genome encodes proteins that 
are modified by acylation285.  One particular type of acylation is palmitoylation. 
Specifically, S-palmitoylation is the addition of 16-carbon saturated fatty acid to cysteine 
residues via labile thioester linkage to both soluble and integral membrane proteins. 
This attachment makes S-palmitoylation unique among lipidations because it is 
reversible, allowing for dynamic regulation. S-palmitoylation was first shown to be 
reversible less than a decade after the discovery of acylation286.  N-palmitoylation is 
irreversible due to the addition of a stable amide bond. For the purpose of this thesis, 
“palmitoylation” will refer to the reversible S-palmitoylation.  
Many different types of proteins are modified by palmitoylation. As such, 
palmitoylation can control different protein properties not just simply trafficking to the 
PM, and has also been shown to target proteins to precise microdomains such as lipid 
rafts (membrane specializations containing sphingolipids and cholesterol)287 or 




and Golgi), affecting their subcellular location288. Though there in no real consensus 
sequence for determining palmitoylation sites, some information has been gleaned 
about palmitoylation sites on different types of proteins like cytosolic and integral 
membrane proteins. Cytosolic proteins are usually palmitoylated at cysteines found near 
the N- or C-terminus and near basic residues, which facilitate membrane interactions 
with acidic lipid head groups. This is not always the case because there are also 
instances of cytosolic proteins modified by palmitoylation at internal sites or sites near 
other hydrophobic lipid modifications. One classic, well-studied example of cytosolic 
protein palmitoylation is H-Ras, palmitoylation cycling of which results in membrane and 
cytosol shuttling289. Integral membrane protein palmitoylation usually occurs at residues 
proximal to the TMD to potentially cooperate with other membrane targeting motifs. Still, 
very little is known about why and where palmitoylation events occur on particular 
cysteines in a given protein. At the very least, it seems like palmitoylation occurs at 
cysteines neighboring membranes largely due to the requirement of proximity to the 
membrane-localized palmitoyl acyltransferases (PATs), discussed in the next section.  
Enzymes governing palmitoylation 
DHHCs 
Palmitate is transferred from palmitoyl-CoA via a cysteine rich domain to cysteine 
residues on the acceptor protein. In the early days of palmitoylation research, it was 
contested whether palmitoylation required a palmitate transferase to catalyze the 
deposition of the palmitate group onto the acceptor protein. This was largely because it 
was shown that palmitoyl linkage could occur spontaneously in vitro in the presence of 




palmitoylation, were discovered in yeast291,292. And in fact, this yeast research 
demonstrated that the majority of palmitoylation was catalyzed by a particular family of 
PATs, the DHHC proteins293. DHHC proteins294 are an integral membrane protein family 
composed of 23 members in mammals and 7 proteins in yeast. DHHC proteins have 
four or more TMDs and a conserved cysteine rich domain (CRD) within a cytosolic loop 
between TMDs. The CRD is a ~50 amino acid stretch containing a D-H-H-C (Aspartate 
–Histidine –Histidine – Cysteine) motif that has been found to be required for PAT 
activity295 (Fig 1.6A). A two-step mechanism has been proposed for DHHC driven 
palmitoylation; first, DHHC is autopalmitoylated through the addition of a palmitoyl 
moiety to the Cysteine in the DHHC motif by way of palmitoyl-CoA and second, the 
substrate is palmitoylated by transfer of the moiety from the DHHC motif296,297 (Fig 
1.6B). The first step involves autopalmitoylation, the palmitoylation of the DHHC family 
members themselves, which appears to be an important intermediate before the 
transfer of the palmitoyl moiety to the substrate. Autopalmitoylation could also act as a 
method to regulate the DHHC enzymatic function or localization to direct it toward 
substrate and confer palmitoylation reaction competency. Due to the large number of 
members in the DHHC family, PATs exert wide-ranging palmitoylation control and 
specificity for substrates and subcellular localization, and thus have the potential for 
diverse and divergent roles in the cell. Adding another layer of complexity, some 
substrates can be palmitoylated by more than one PAT, while others require 
palmitoylation by a single PAT, hinting at functional redundancy between DHHC family 




into the function of the DHHC proteins and molecular mechanism underlying 
palmitoylation298,299. 
Early work determined that much of the palmitoylation in cells is occurring 
through DHHC PAT activity293, but identifying PAT-substrate pairs has proven difficult. 
The substrate specificity of the palmitoylation moiety transfer by the DHHC family of 
proteins could be conferred by the localization of the PAT within the cell. DHHCs are 
found throughout the entire endomembrane system of cells, indicating proteins can be 
modified by palmitoylation at varied cellular localizations throughout their lifetimes300. 
There appears to be substrate redundancy or overlapping specificities between different 
DHHC proteins; accordingly one palmitoylation site on a protein could be the substrate 
for multiple DHHCs throughout the cell. DHHC proteins are mostly ubiquitously 
expressed across multiple cell types but appear to localize to specific compartments 
within cells. It is unknown how the individual DHHC isoforms are targeted within the cell; 
however, we have come to know that the DHHC proteins are often localized to specific 
subcellular compartments, such as DHHC3 in the Golgi, DHHC2 in the synapse and 
within recycling endosomes, and DHHC5/8 at the PM at the PSD. The Golgi appears to 
be particularly saturated with DHHC proteins (12 of 23 DHHC proteins localize to the 
Golgi301), indicating that it is a hub for palmitoylation. However, subcellular targeting of 
DHHC proteins might depend on cell type302. Apart from the highly conserved DHHC-
CRD, the remainder of the DHHC protein sequence is quite divergent. The NTD and 
CTD of DHHCs could confer some localization specification. For example, DHHC3, 5 
and 8 all contain PDZ-binding motifs, which is important for substrate recruitment and 




determine if the NTDs or CTDs confer substrate specificity303. Overall, the different 
subcellular localizations of PATs allows for an additional level of dynamic control of 
protein palmitoylation to ensure proper coupling of activity/extracellular signaling to PAT 
function. 
The large size of the DHHC family has also contributed to the difficulty in 
identifying specific PAT-substrate pairings. Nonetheless, using candidate based 
approaches and coexpression studies, a number of pairs have been identified303. For 
example, PSD-95 is palmitoylated by both DHHC2 and DHHC3; DHHC2 palmitoylation 
is more important during synaptic activity for the dynamic recruitment of PSD-95 to the 
synapse while DHHC3 constitutively palmitoylates PSD-95 in the Golgi304. As more 
pairs are identified, it will be easier to pull out DHHC-specific consensus sequences. 
Contributing to this difficulty, there is no current method to visualizing palmitoylated 
proteins in cells (apart from a PSD-95 specific intrabody that identifies palmitoylated 
PSD-95), which is much different than other modifications such as phosphorylation. 
DHHC knockout mice have helped determine some function and substrate 
information303,305. These mouse models will be discussed in more detail below.  
PPTs  
Palmitoylation is removed by protein palmitoylthioesterases (PPTs), which are far 
less studied than the PATs. PPTs, in contrast to PATs, hydrolyze S-acylated cysteines 
to remove palmitoylation. They belong to the serine hydrolase superfamily that 
constitutes ~115 genes in the human genome306. Only a handful of PPTs have been 
identified. This woefully small list so far contains PPT1, APT1, and several ABHD 




encoding for PPT1 have been implicated in neurological disorders. PPTs were thought 
to be localized only to the lysosome where evidence showed they aided in lysosomal 
degradation of fatty-acid modified proteins. However, it was demonstrated that protein 
palmitoylthioesterase-1 (PPT1) is distributed throughout neurons, in the soma and 
neurites308. PPT1 expression is regulated developmentally and spatially and correlates 
with synapse development309, with preferential targeting to axons over dendrites in 
mature neurons. Acylprotein thioesterase-1 (APT1) is thought to remove palmitoylation 
from the cytosolic surface of membranes. It is unknown how PPTs are regulated, 
though APTs are thought to act ubiquitously due to the need for tight control of 
palmitoylation. Several ABHD proteins have also been shown to have PPT activity306. 
Work looking at inhibition of serine hydrolases using the drug 
hexadecylfluorophosphonate (HDFP) showed that depalmitoylation of a number of 
proteins was blocked in the presence of the drug. The majority of the HDFP-sensitive 
serine hydrolases contain an alpha/beta-hydrolase fold domain (ABHD) and act as 
PPTs310. ABHD17311 depalmitoylates N-Ras and PSD-95 and it is proposed that ABHDs 
might be more specific in substrates than other PPTs. While some proteins are 
palmitoylated just after translation and remain palmitoylated for the lifetime of the 
protein, other proteins go through palmitoylation and depalmitoylation cycles. 
Palmitoylation and depalmitoylation cycles can be dynamically or constitutively 
regulated by cellular processes or signaling to allow for exchange of proteins between 
different cellular compartments. Palmitoylation appears to be important for protein 
stability because depalmitoylation is essential for protein degradation312 and 





Figure 1.6: The DHHC proteins and palmitoylation mechanism.  
A. Schematic of the general structure of the DHHC family of proteins, containing four 
transmembrane domains and a cysteine rich domain containing the DHHC motif 
important for catalyzing the transfer of palmitoyl moieties onto target proteins. B. The 





reaction to palmitoylation, depalmitoylation is also incredibly important for normal 
cellular function. 
Detecting palmitoylation in cells 
Historically it was quite difficult to assess palmitoylation state due to the 
previously mentioned lack of consensus sites paired with lack of detection methods. 
Unlike phosphorylation, there are virtually no antibodies for detecting palmitoylation 
modifications on proteins. However, over the past twenty years progress in 
palmitoylation research has been exponential due to the advancement in detection 
methods, most of which are biochemical. These methods have varying levels of 
quantitation, sensitivity and amenity to different cells systems. Methods to detect 
palmitoylation can be broadly grouped into two categories, metabolic labeling and 
biochemistry/biotin exchange313 (Fig 1.7).  
Metabolic labeling 
Metabolic labeling (Fig 1.7A), the most commonly used technique to detect 
palmitoylation, utilizes synthetic analogues of fatty acids with biorthogonal tags that get 
incorporated onto cysteines of modified proteins.  The oldest method for detecting 
palmitoylation is radioactive labeling284, where cells are fed tritiated palmitate that is 
incorporated into proteins and visualized using autoradiography314,315. One shortcoming 
of this technique is that it depends on the palmitoylation turnover of a protein of interest, 
because the radiolabeled palmitate must have time to be incorporated into the 
endogenous protein. In this way, radiolabeled palmitate can be used in pulse-chase 
style experiments to measure the half-life of protein palmitoylation. As with any 




method. Further, this approach is only able to monitor palmitoylation of a single protein. 
It cannot be directly used to identify palmitoylation sites and requires mutations of 
predicted palmitoylation sites and good antibodies to the target areas of the protein to 
attempt palmitoylation site discovery. Finally, there are some concerns about the 
specificity of the labeling due to nonspecific labeling of other non-palmitoylation fatty 
acylation. Needless to say, radiolabeling proved useful early on but has since been 
replaced by more tenable methodologies.  
To combat the problems with radioactivity, click chemistry using biorthogonally 
labeled analogs of palmitic acid (either alkyne or azide tagged) was combined with 
metabolic labeling316. This method has also been used successfully paired with mass 
spectrometry (MS)316,317, stable isotope labeling with amino acids in cell culture 
(SILAC)294 and pulse-chase experiments318-320. Click chemistry has been successfully 
paired with proximity ligation assays (PLA); this method must use fixed cells but can be 
used to image palmitoylated protein localization using subcellular compartment 
markers321. Pairing PLA with click chemistry is the only current method for visualizing 
palmitoylation in situ. A similar issue with click chemistry plus metabolic labeling and 
radiolabeling is that there is no way to standardize palmitoylated protein levels to the 
unpalmitoylated protein levels. This approach is useful in cell culture systems but has 
dubious in vivo applications owing to the potent inhibitory effect of the most common 
fatty acid analogues used in click chemistry methods on cytochrome P450 hydroxylase, 




Biochemical approaches to palmitoylation detection 
Biochemical methods (Fig 1.7B) for detecting palmitoylation take advantage of 
protection of free thiol groups with N-ethylmaleimide (NEM) followed by hydroxylamine 
cleavage of palmitoyl groups. This method was first described322 paired with radioactive 
alkylation reagents read out by autoradiography and proved to be more sensitive than 
metabolic labeling and can be used in cells and tissues313. Further iterations of this 
technique, lacking radiolabeling have been developed. Three main methods of detection 
using biochemical techniques are: acyl-biotin exchange, acyl-RAC, APEGs. The first 
development was acyl-biotin exchange (ABE); ABE utilizes protection of free thiol 
groups with NEM, cleavage of palmitoylation moieties with hydroxylamine (HAM), 
however the final step is to label the newly freed thiols with biotin. This method can be 
used with the downstream readout of western blotting or MS. Due largely to a lack of 
consensus sequence, the palmitoylproteome was studied early on in yeast through 
proteomics and ABE chemistry322 by labeling all palmitoylated proteins to pull them 
down and affinity-purify with streptavidin for processing with tandem MS-based 
proteomics293. This technique was also used to study synaptosomes from rat brains323 
and probe specifically for the proteins that are palmitoylated at neuronal synapses. A 
further extension of this method has also been successfully employed using western 
blotting to analyze the palmitoylation state of specific proteins of interest324,325. The ABE 
method has a few caveats, largely coming from the sample preparation methods. Like 
the metabolic labeling approaches, the ABE method also does not provide information 
about the exact site of palmitoylation. In order to isolate the palmitoylated proteins, a 





Figure 1.7: Palmitoylation detection techniques.  
A. Metabolic labeling techniques; historically metabolic labeling was used to detect 
palmitoylation of a targeting protein using either radioactivity or biotin/fluorescence. B. 
More recently, more user friendly and sensitive biochemical techniques have been 
developed for use in combination with western blotting and mass spectrometry with the 





Another consideration is that all free cysteines must be blocked in order to assure there 
are no false positives; similarly, incomplete thioester hydrolysis and/or biotin labeling 
can cause false negatives. The ABE method allows for quantitative analysis and the 
ability to enrich samples for palmitoylated proteins increasing signal to noise. As an 
alternative approach to ABE, researchers have used resin-assisted capture (Acyl-RAC), 
which replaces the biotin pulldown steps with a direct conjugation to a resin containing 
groups that are reactive with thiols326,327. Acyl-RAC can be paired with MS and has 
similar limitations as the ABE method. 
The most recent development in biochemical palmitoylation detection methods is 
Acyl-PEG exchange (APE). APE uses NEM protection and HAM to cleave thioesters 
like the previous biochemical methods but directly labels the individual groups with 
maleimide-conjugated polyethylene glycol polymers. This causes a molecular weight 
shift in the labeled protein when resolved with western blotting, Acyl-PEG exchange gel-
shift (APEGs)306,328. APE shares the same shortcomings as the above mentioned 
biochemical assays, but has the distinct advantage of being internally controlled and 
able to separate distinct palmitoylation states within the same sample (i.e. if a protein is 
modified by multiple palmitoyl-moieties, the ratio of unpalmitoylated to mono-
palmitoylation to dual-palmitoylation etc. can be compared). 
Overall, protein palmitoylation has been demonstrated to be a complex and 
dynamic way to alter protein function and localization; palmitoylation of a single cysteine 
includes a complicated cascade of events from the identification of the site, the 
palmitoylation event by a particular PAT, depalmitoylation by a specific PPT, and the 




of which can contribute to the effect that palmitoylation has on properties of the 
palmitoylated protein. However, there is much to understand about the process of 
palmitoylation cycling and how it influences many different cellular processes both 
physiologically and under nonphysiological conditions. 
Synaptic protein palmitoylation  
Considering the complex architecture of the neuron, with long ranging projections 
like axons and extensive processes like dendrites, it is not surprising that neurons 
require precise protein trafficking and localization to ensure proper functioning. 
Neuronal proteins are lipidated most frequently through palmitoylation294, which have 
emerged as a useful means within neurons to ensure for proper protein distribution. It 
has long been appreciated that neuronal proteins can be modified by palmitoylation323 
and palmitoylation is quite common among neuronal proteins; it is thought that upward 
of ~40% of synaptic proteins are palmitoylated329, including cytoplasmic and integral 
membrane proteins, such as enzymes, receptors330, and scaffolds331. Palmitoylation is 
important in a number of synaptic processes including: axon guidance, synaptic vesicle 
fusion, protein sorting and trafficking, receptor clustering, and protein scaffolding at the 
synapse332. Importantly, half of all DHHC proteins are expressed in the brain333 with 
different levels of expression across different brain areas and with particular family 
members localizing to synaptic sites. Indeed, DHHCs1, 2, 5, 8 and 12 have been found 
in dendrites and DHHCs 2, 5 and 8 are expressed at the neuronal PM and found within 
subsynaptic compartments333. DHHC protein targeting within the cell is still a problem 
yet to be solved and it is still unknown how DHHC proteins acquire information about 




One classic example of a neuronal protein undergoing dynamic protein 
palmitoylation cycling is the important synaptic scaffold PSD-95, one of the first synaptic 
palmitoylation substrates to be studied. PSD-95 is the predominate organizer of the 
post-synaptic density and has been found, using super-resolution fluorescence imaging 
techniques, to organize into heterogeneous and dynamic nanoclusters78,79,334. PSD-95 
palmitoylation is necessary for localization to the synapse331,335 and localization to the 
membrane302; a palmitoylation-deficient mutant of PSD-95 is completely cytosolic336. 
Palmitoylation of PSD-95 also limits its lateral movement within the plasma membrane 
once the protein is at the synapse334. PSD-95 palmitoylation is dynamic with palmitate 
half-life around two hours, which is controlled in a activity-dependent manner332. PSD-
95 palmitoylation cycles can happen within a single dendritic spine and individual PSD-
95 nanodomains can undergo rapid and continuous palmitoylation and 
depalmitoylation302,334. Palmitoylation of PSD-95 has been found to also regulate 
downstream processes and associated proteins. AMPAR localization to synapse is 
correlated with PSD-95 palmitoylation, with a decrease in AMPAR synaptic occupancy 
with decreased PSD-95 palmitoylation337. It was later discovered that PSD-95 could be 
palmitoylated by both DHHC3 and DHHC2304 and recent work out of the Fukata 
laboratory identified the ABHD17 family as PPTs that depalmitoylate PSD-95306.  
Palmitoylation in neuronal pathology 
Not surprisingly, due to the extensive list of proteins modified by palmitoylation 
and dependent on this modification for proper protein function, multiple components of 




true in neurological disorders313, such as in neurodegenerative disorders like 
Alzheimer’s disease, Huntington’s disease and infantile neuronal ceroid lipofuscinosis. 
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, 
characterized by large protein aggregates in the brain causing neuronal dysfunction 
resulting in memory loss and cognitive decline.  The hallmark pathological feature of AD 
is amyloid plaques caused by aggregation of the protein beta-amyloid (Aβ). Aβ is 
derived from amyloid precursor protein (APP) through proteolytic cleavage by β-
secretase (BACE1) and γ-secretase. APP is normally processed by α-secretase 
resulting in non-amyloidogenic species; amyloidogenic species of Aβ are created by 
APP cleavage by BACE1 then γ-secretase, sequentially. This pathogenic form of Aβ 
can go on to form the plaques characteristic in AD patient brains. A number of genetic 
mutations have been identified that predispose individuals for early-onset familial AD, 
such as in APP and presenilin, a protein important for amyloidogenic cleavage of APP 
in the γ-secretase complex338. Palmitoylation has been found to be an important 
regulator of a number of important proteins in AD, including APP and BACE1338. APP is 
palmitoylated and this palmitoylation has been implicated in amyloidogenic processing 
of APP. Palmitoylated APP associates with lipid rafts and promotes cleavage by BACE1 
rather than α-secretase339. BACE1 is also palmitoylated, though it is controversial what 
role this modification plays in amyloidogenesis and AD. There is evidence both that 
BACE1 palmitoylation enhances Aβ production and also that it has no effect at all338. A 
recent study targeted BACE1 palmitoylation specifically using a knock-in mouse model 
mutating the four cysteine residues that are palmitoylated to unpalmitoylatable 




a significant decrease in amyloid burden and resistance to cognitive decline when 
crossing the BACE1 mutant with a mouse model of AD340. While there are hints that 
palmitoylation of key AD players could influence cognitive function, much more needs to 
be understood about AD pathology and palmitoylation in AD pathogenesis.  
Huntington’s disease (HD) in a neurological disorder caused by a poly-glutamine 
(poly-Q) expansion in the huntingtin protein. A hallmark of this disease is protein 
aggregation within cells that is thought to arise from protein misfolding due to the polyQ-
repeats. Huntingtin-interacting-protein-14 (HIP14) was discovered to have PAT activity, 
also known at DHHC17341. Huntingtin is a strong candidate to be a substrate for HIP14 
palmitoylation and mutant huntingtin appears to be less palmitoylated than wild type 
(WT). Further, less palmitoylation of mutant huntingtin was associated with more 
aggregation and more toxicity to cells342. A mouse model exhibiting less than 10% WT 
protein levels of HIP14/DHHC17 has decreased striatal volume, loss of medium spiny 
neurons, decreased excitatory synapses, impaired hippocampal LTP and memory, and 
deficits in motor behaviors302. Interestingly, a more similar phenotype to HD mouse 
models is observed in DHHC13 KO mice302. However, it is unclear how these two PATs 
converge in humans and how they may contribute to human HD has yet to be 
determined. 
Infantile neuronal ceroid lipofuscinosis (INCL) is a neurodegenerative disorder in 
children caused by a variety of mutations in the PPT1 gene343. The disease results from 
a nearly total loss of cortical neurons as well as causing vision loss due to retinal cell 
loss. This initial loss of neurons is followed by massive glial proliferation, resulting in 




dysfunction and aberrant depalmitoylation343. PPT1 knockout mice recapitulate the 
human disease, with progressive cortical neuron loss and seizures, resulting in early 
death344,345.  
Evidence that palmitoylation is implicated in cognitive function was found by 
creating transgenic mice altering various DHHC family members. DHHC8 KO 
homozygotes have axonal growth and branching abnormalities, while heterozygotes 
have impaired working memory346. DHHC8 mutants exhibit sex-specific behavioral 
deficits with pre-pulse inhibition and locomotor activity due to increased fear in female 
mice. Related to these schizophrenia-associated phenotypes, regions of the DHHC8 
gene in humans have been connected to schizophrenia susceptibility347,348 and 
microdeletions in this gene region show cognitive deficits and ~30% develop 
schizophrenia346. The phenotypes observed between DHHC5 and DHHC8 mutants are 
overlapping, not surprisingly due to their homology. Studies with a DHHC5 hypomorph, 
which only display ~7% of the protein expression of WT, is born at half the rate 
expected and has a significant deficit in contextual fear conditioning and hippocampal 
learning349. DHHC5 is known to palmitoylate GRIP1325 and δ-catenin350 among other 
synaptic proteins. Additionally, DHHC9 mutations have been implicated in X-linked 
intellectual disability351. As a final example, DHHC2 is a tumor suppressor that is lost in 
a number of metastatic cancers302 and was found to be important in control of cell 
morphology.  
Thus, emerging evidence suggests that palmitoylation and the enzymes that 




including neurodevelopmental and neuropsychiatric conditions, further highlighting the 
importance of studying these complex but essential mechanisms.  
AKAP79/150 palmitoylation 
Proteomics experiments from rat synaptic membranes identified AKAP79/150 as 
a palmitoylated protein323. Our laboratory subsequently identified the sites of 
AKAP79/150 palmitoylation on two conserved Cys residues within the N-terminal 
membrane-targeting domain247. Palmitoylation of AKAP is not a requirement for 
membrane targeting, unlike cytosolic proteins, because a mutant AKAP79 that cannot 
be palmitoylated (achieved by mutating the two Cys to Ser) is still targeted to the PM. 
However, palmitoylation appears to target AKAP79/150 to specific membranes, namely 
the RE and lipid rafts in the PSD247,264. Glycine chemical LTP (cLTP) stimulation and 
kainate-induced seizures increase AKAP79/150 palmitoylation while NMDA cLTD 
decreases AKAP79/150 palmitoylation247,265. Interestingly, AKAP79/150 palmitoylation 
state correlates with its occupancy in dendritic spines, with more palmitoylation 
correlating with more spine occupancy. If a palmitoylation-deficient AKAP79 (AKAP79 
CS) is acutely overexpressed in cultured rat hippocampal neurons, AKAP79 shows a 
decreased colocalization with endosomal markers (transferrin receptor [TfR], early 
endosome antigen 1 [EEA1]) and is less strongly associated with the PSD, as 
demonstrated by easier removal from spines with detergent extraction and NMDA 
treatment247. This palmitoylation-deficient AKAP CS mutant resulted in enhanced basal 
transmission by whole-cell voltage clamp experiments recording mini excitatory post-
synaptic currents (mEPSCs) and impaired cLTP response with no increase in AMPAR-




(SEP)-TfR imaged exocytosis from REs. Further work by our laboratory identified 
DHHC2 as the PAT responsible for AKAP79/150 palmitoylation248. Micro-RNA 
interference (RNAi)-mediated knockdown of DHHC2 largely phenocopied AKAP79 CS 
overexpression with enhanced RE exocytosis and increased basal AMPAR-mediated 
transmission. Thus, AKAP79/150 palmitoylation appears to regulate a number of 
important synaptic properties important for both basal and activity-induced transmission. 
It follows that, AKAP79/150 palmitoylation could be important for organizing synapses 










AKAP79/150 provides a focal point for the intersection of two prominent 
intracellular signaling pathways: phosphorylation and palmitoylation. In particular, 
AKAP-anchored CaN and PKA afford phospho-regulation of AMPARs but for this 
signaling complex to exert its control on the receptor it must be in close proximity to the 
receptors in the membrane, which can be directed by palmitoylation. Given the previous 
research on AKAP79 CS overexpression in rat hippocampal cultures, AKAP 
palmitoylation appears to be important in synaptic transmission and plasticity. However, 
being unable to test a number of plasticity relevant measures and chronic effects of 
AKAP palmitoylation ablation, we turned to a knock-in transgenic mouse approach. We 
developed an AKAP CS mouse, which has Cys36 and 123 mutated to Serines to 
prevent AKAP150 palmitoylation. Chapter III is composed of a published manuscript 
detailing the characterization of this AKAP CS mouse in mice aged 2-3 weeks. Chapter 
IV details future directions and unpublished data from AKAP CS cultures and acute 
slices from young mice exploring more mechanisms of AMPAR function. Chapter V 
concludes with discussion and future directions. 
Research question 
How does palmitoylation of AKAP150 control subcellular targeting within neurons and 






1. Understand how AKAP150 palmitoylation influences sub-synaptic protein localization 
2. Characterize the involvement of AKAP150 palmitoylation in synaptic transmission 
and plasticity 
Hypotheses 
I hypothesize that AKAP150 palmitoylation controls the localization of AKAP to 
key nanodomains within spines and dendrites, such as the core PSD and REs, which 
are essential to synaptic function. Further, due to the enzyme anchoring of CaN and 
PKA, palmitoylation of AKAP ensures proper downstream signaling, including the 
phospho-regulation of the AMPAR. I expect that AKAP palmitoylation will be required for 
maintaining proper synaptic function basally and during various forms of synaptic 









 AKAP150 PALMITOYLATION REGULATES SYNAPTIC INCORPORATION OF 
 CA2+-PERMEABLE AMPARS BASALLY AND DURING LTP2  
Introduction 
AMPARs are the primary mediators of fast excitatory neurotransmission in the 
central nervous system and regulation of the number and activity of post-synaptic 
AMPARs is crucial for forms of synaptic plasticity that support learning and memory, 
including NMDA receptor (NMDAR)-dependent LTP and LTD99. AMPARs are tetramers 
assembled from GluA1-4 subunits, with incorporation of GluA2 subunits decreasing 
channel conductance and inhibiting Ca2+ influx. After the early postnatal period, the 
majority of AMPARs at hippocampal CA1 synapses under basal conditions are Ca2+-
impermeable GluA1/2 or GluA2/3 heterotetramers16,124,127. However, Ca2+-permeable 
GluA1 homomeric receptors (CP-AMPARs) can be recruited to hippocampal synapses 
from extrasynaptic and/or intracellular stores to regulate synaptic strength during LTP, 
LTD, and homeostatic plasticity36,103,104,107,108,167,275,352-354; but see129,131. These recruited 
CP-AMPARs, due to both greater single channel conductance and Ca2+-permeability, 
can in turn not only influence the level of plasticity expression but also alter the capacity 
of synapses to undergo subsequent plasticity, so called meta-plasticity. Importantly, CP-
AMPAR-mediated meta-plasticity in the nucleus accumbens and amygdala are, 
respectively, linked to reward learning relevant for drug addiction and fear memory 
extinction relevant for post-traumatic stress disorder201,355. However, the roles of CP-
                                            
2 Portions of this chapter were previously published in Cell Reports and are included 




AMPARs in regulating LTP/LTD and meta-plasticity at hippocampal synapses relevant 
for spatial and contextual learning and memory are less clear and remain controversial.  
We know that phosphorylation and dephosphorylation of S845 in the GluA1 C- 
terminal domain by the cAMP-dependent protein kinase PKA and the Ca2+-calmodulin- 
dependent protein phosphatase 2B/calcineurin (CaN) regulates CP-AMPAR synaptic 
insertion and removal, respectively166-169,356-359. However, we still do not understand how 
post-synaptic PKA and CaN signaling are coordinated to control CP-AMPAR trafficking 
between intracellular compartments, such as REs, the extrasynaptic membrane, and 
the PSD. An increasing body of evidence indicates that the scaffold protein 
AKAP79/150 (human79/rodent150; Akap5 gene) targets both PKA and CaN to 
AMPARs to regulate GluA1 phosphorylation and trafficking to control LTP/LTD balance 
and homeostatic potentiation103,104,275,280,281,354,360,361. Thus, a key question is how is the 
post-synaptic localization of AKAP79/150 itself regulated.  
AKAP79/150 is targeted to the post-synaptic PM primarily by an N- terminal poly-
basic domain that binds to PIP2, cortical F-actin, and cadherin adhesion molecules and 
secondarily by an internal domain that binds PSD-95, a major structural scaffold of the 
PSD245,249,262,267,269. More recently we discovered that AKAP79/150 is S-palmitoylated 
on two conserved Cys residues (C36 and C129 human/123 mouse) within the N-
terminal targeting domain by the RE-localized palmitoyl acyltransferase DHHC2247,248. 
AKAP palmitoylation is not required for its general targeting to the PM or its binding to 
F-actin245 but is required for its specific localization to dendritic REs and association with 
cholesterol-rich, detergent-resistant membrane lipid rafts247,264. Of note, the PSD is 




are palmitoylated and lipid-raft associated, including PSD-95247,287,294,304,332-334. 
However, it is not known if AKAP79/150 palmitoylation also controls its association with 
the PSD.  
In contrast to other protein lipidations like myristoylation and prenylation, 
palmitoylation is reversible, with palmitate removal being catalyzed by protein palmitoyl 
thioesterases306. Importantly, palmitoylation of PSD-95, AKAP150 and other PSD 
scaffolds is affected by seizures and anticonvulsants in vivo and has been implicated in 
regulating AMPAR trafficking and synaptic strength in cultured neurons in 
vitro247,248,323,325,332,350,361,362. In particular, AKAP79/150 palmitoylation and dendritic 
spine targeting are bidirectionally regulated by neuronal activity in cultured neurons to 
coordinately control a number of cellular correlates of LTP/LTD, including RE 
exocytosis, spine morphology, GluA1 surface expression, and AMPAR synaptic 
activity247,248,265. However, we do not know whether palmitoylation controls AKAP79/150 
post-synaptic localization or AMPAR regulation during synaptic plasticity in the intact 
circuitry of the hippocampus in vivo. In addition, despite the prominence of 
palmitoylation modifying PSD proteins, no in vivo models have been developed to 
specifically disrupt palmitoylation of a specific post-synaptic protein and then determine 
the impacts on synaptic function. Importantly, here we developed a palmitoylation-
deficient AKAP150 C36, 123S (AKAP CS) knock-in mutant mouse line to characterize 
the role of AKAP palmitoylation in regulating its targeting to the PSD and in controlling 





• Determine the effect of AKAP150 palmitoylation on sub-synaptic protein 
localization 
• Characterize the regulation of synaptic transmission and plasticity by AKAP150 
palmitoylation 
Materials and methods 
Generation of AKAP150 CS knock-in mice 
The Transgenic and Gene Targeting Core at the University of Colorado Anschutz 
Medical Campus constructed the Akap5CS targeting vector. The Akap5CS mutation 
introduced mutations of AKAP150 cysteines 36 and 123 to serines in the single coding 
exon of an Akap5 genomic DNA fragment via piggyBac (PB) transposon based method 
from a C57BL/6 BAC clone. In this targeting vector, the AKAP150 CS mutation was 
introduced by piggyBac method with a neomycin resistance cassette flanked by the 3’ 
and 5’ long-terminal repeat (LTR) of PB inserted within the Akap5 exon. The targeting 
construct was electroporated into a hybrid C57BL/6 129 embryonic stem (ES) cell line 
EC7.1 and G418-resistant clones were screened for homologous recombinants by 
PCR-based genotyping. The neomycin resistance cassette was then removed from the 
targeted locus by remobilizing the PB with transient expression of PB transposase. One 
positive clone was expanded, injected into blastocysts, and implanted into surrogate 
mothers. Chimeric F0 founders were born and bred to C57BL/6J to establish germ-line 
transmission. F1 mice heterozygous for the CS mutation were identified and then bred 
to yield F2 CS homozygous offspring. For PCR genotyping, DNA was extracted from tail 




manufacturer’s protocol. PCR with forward (5’- GGAGACCAGCGTTTCTGAGATT-3’) 
and reverse (5’- ATCTCCAAATCGTCTGCCTCTC-3’) primers amplified the mutated 
region of the coding sequence, giving a 461 bp fragment for both the WT allele and the 
CS allele. After PCR amplification, the samples were digested with HindIII for 90 
minutes and then resolved on a DNA gel. For the WT allele, no fragment will result from 
cutting (461 bp fragment) while the CS allele results in two fragments (100, 360 bp). 
AKAP150 CS mice were backcrossed to C57BL several generations but then 
maintained on a mixed C57BL/6J 129 background. Both male and female mice between 
the ages of P12-21 were used for experiments and analyzed together. Mixed litters of 
male and female neonatal day 1-3 mouse pups were used for cultures. All animal 
procedures were conducted in accordance with National Institutes of Health (NIH)–
United States Public Health Service guidelines and with the approval of the University of 
Colorado, Denver, Institutional Animal Care and Use Committee.  
Primary mouse hippocampal neuron culture  
Mouse hippocampal neurons were cultured from postnatal day 1–3 mixed sex 
mice as previously described275,354. Briefly, the hippocampus was dissected from 
postnatal day 1–3 AKAP150 WT or CS mice and dissociated in papain. Neurons were 
seeded at a density of 150,000-200,000 cells/well in 12 well dishes on 18 mm glass 
coverslips coated with poly-D-lysine and Laminin or 400,000-500,000 cells/well in 6 well 
dishes on 25 mm glass coverslips coated with poly-D-lysine and laminin (BD 
Biosciences). Cells were maintained at 37°C, 5% CO2 in Neurobasal-A medium 




Fractionation and immunoblotting of brain tissue 
Subcellular fractionation and immunoblotting of WT and CS hippocampal or 
forebrain (cortex and hippocampus) lysates were performed as in104,275,363,364. For 
immunoblotting, 15 µg of whole extract (WE), 10 µg of P2, 20 µg of S2, 5 µg of TxP, and 
15 µg of TxS were resolved on Tris-SDS gels and transferred in 20% methanol to PVDF 
membranes. Membranes were incubated with primary antibodies for 2 hours as follows: 
rabbit anti-AKAP150 (1:1000)365, mouse anti-PKA-RIIβ (1:1000; BD Biosciences 
Transduction Laboratories), mouse anti-PSD-95 (1:1000; Millipore), rabbit anti-GluA1 
(1:1000; Millipore), and rabbit anti-GluA1-S845 (1:1000; Millipore). Signal detection was 
performed using Horse Radish Peroxidase (HRP)-coupled secondary antibodies (Bio-
Rad; 1:10,000) followed by ECL (West Pico or West Dura Chemiluminescent Substrate; 
Pierce). Chemiluminescence was imaged using an Alpha Innotech Fluorchem gel 
documentation system, and band intensities were analyzed using ImageJ (NIH). Band 
intensities were normalized to WT WE from the same blot.  
APEGS palmitoylation assay  
AKAP150 palmitoylation state was assessed using the APEGS (Acyl-PEG 
Exchange Gel-Shift) assay as previously described265,306. Forebrain whole extracts or 
subcellular fractions from above were tumbled in PBS buffer containing 4% SDS and 5 
mM EDTA with 20 mM TCEP for 1 h at room temperature in the presence of protease 
inhibitors. Next, free thiols were blocked by incubation with 50 mM N-ethylmaleimide 
(NEM) overnight at room temperature. Following a chloroform-methanol precipitation 
(CMP), pellets were resuspended in 4% SDS PBS buffer and thioester bonds were 




over end rotation. After another CMP, free thiols were labeled with 10 kD polyethylene 
glycol moieties (SUNBRIGHT maleimide PEG, NOF America) for 1 h at RT with 
rotation. Following a final CMP, samples were re-suspended and boiled in sample buffer 
with 50 mM dithiothreitol and resolved via SDS-PAGE and western blotting with 
AKAP150 antibody.  
Extracellular fEPSP recordings  
For slice preparation, animals (P12-P21) were decapitated under anesthesia with 
isofluorane. The brain was removed into 4°C cutting solution (in mM: 3 KCl, 1.25 
NaH2PO4, 12 MgSO4, 26 NaHCO3, 0.2 CaCl2, 220 sucrose, 10 glucose; all chemicals 
were purchased from Sigma-Aldrich.). Hippocampi were removed from the brain, and 
400-µm-thick slices were made using a McIIwain tissue chopper. Slices were recovered 
at 29-31 °C for >90 min in artificial cerebrospinal fluid (ACSF)/cutting solution mixture 
(ACSF in mM: 126 NaCl, 5 KCl, 2 CaCl2, 1.25 NaH2PO4, 1 MgSO4, 26 NaHCO3, 10 
glucose, 2 N-acetyl cysteine). Following recovery, slices were transferred to a recording 
chamber and maintained at 29-31°C in ACSF as described above (without N-acetyl 
cysteine). A bipolar tungsten stimulating electrode was placed in the Schaffer collateral 
pathway to evoke field excitatory post-synaptic potentials (fEPSPs) recorded in CA1 
stratum radiatum using a glass micropipette filled with ACSF. Input/Output (I/O) curves 
were measured by evoking fEPSPs at various intensities until maximal response was 
determined by plotting initial fEPSP slope against stimulus intensity. For studies of LTP, 
LTD, and de-depression, the test stimulus intensity was set to evoke 40–60% of the 




Whole-cell electrophysiology  
For whole-cell voltage-clamp electrophysiological recordings, 300 µm horizontal 
hippocampal slices were prepared as above (cutting solution in mM: 85 NaCl, 75 
sucrose, 2.5 KCl, 1.3 NaH2PO4 monobasic, 24 NaHCO3, 0.5 CaCl2, 4 MgCl2, 25 D-
Glucose) using a Vibratome. After 30 minutes at 31.5 °C, slices were recovered at room 
temperature for >60 minutes in ACSF/cutting solution mixture (ACSF in mM: 126 NaCl, 
2.5 KCl, 1 NaH2PO4 monobasic, 26.2 NaHCO3, 2.5 CaCl2, 1.3 MgSO4-7H20, 11 D-
Glucose at ~290 mOsm). Slices were transferred to a recording chamber and 
maintained at 29.5 °C and visualized using infrared–differential interference contrast 
microscopy. Pipettes had a resistance between 2 and 5 MΩ. CA1 pyramidal neurons 
were held at -70 mV and recorded from using an intracellular solution containing the 
following (in mM): 115 Cs-Methanesulfonate, 15 CsCl, 8 NaCl, 10 Tetraethylammonium-
Cl, 0.2 EGTA, 2 Mg-ATP, 0.3 Na-GTP, 10 HEPES, 10 Na2- phosphocreatine, 1 MgCl2, 
pH 7.3 with CsOH at ~300 mOsm. AMPAR sEPSCs were isolated using 50 µm 
picrotoxin (Tocris) and mEPSCs were isolated with the addition of 0.5 µm tetrodotoxin 
(TTX, Tocris) extracellularly. For hippocampal cultures, coverslips were transferred to 
ACSF containing 0.5 µm TTX and 50 µm picrotoxin or 0.5 µm TTX, 50 µm picrotoxin 
and 70 µM IEM1460 and then recorded from as above.  
For Evoked EPSCs, a bipolar tungsten stimulating electrode was placed as in the 
field experiments and CA1 pyramidal cells were recorded from using an internal solution 
containing 5 mM N-Ethyllidocaine (QX-314) to prevent action potential firing. Baseline 
responses were established in whole-cell mode and then currents were evoked at 




assess outward AMPAR and NMDAR current. Traces (≥5) were averaged across 
recordings from a single neuron at each respective holding potential to calculate 
AMPA/NMDA ratios. AMPA currents were measured at the peak amplitude of the EPSC 
at both +40mV and -70mV divided by NMDA current at 50 ms after the onset of the 
EPSC at +40 mV. For NASPM sensitivity, ACSF containing 20 µM NASPM was washed 
on after establishing a baseline evoked response and the change in response was 
calculated as EPSC amplitude after NASPM /EPSC amplitude before NASPM.  
For Evoked I/O curves, responses were established at various stimulus 
intensities and fixed multiplier setting. For PPR, baseline responses were established in 
whole-cell mode and then paired-pulses at various intervals were recorded at -70 mV to 
assess paired-pulse facilitation as a read out of pre-synaptic function.  
For AMPA rectification measurements, AMPAR currents were isolated using 100 
µM DL-APV (Tocris) and 50 µM Picrotoxin in extracellular solution and with 10 µM 
spermine and 5 mM QX-314 (Tocris) in the internal solution. Baseline responses were 
established in whole-cell mode and the currents were evoked at different holding 
potentials (-70, -40, -20, 0, +20, +40 mV). Rectification index was calculated by taking 
the -70 mV amplitude/+40 mV amplitude, resulting in a larger number for more rectifying 
channels/CP-AMPARs. For NMDA I/O measurements, NMDAR currents were isolated 
using 10 µM NBQX and 50 µM Picrotoxin. +40 mV responses were established at 
various stimulus intensities and fixed multiplier settings. For LTP experiments, slices 
were stimulated for 10-15 min at moderate stimulus intensity before going into whole- 
cell mode. Once a cell was patched, baseline was established within 5 min of breaking 




tetanized. Cells were then stepped back down to -70 mV and recorded for 50-60 min 
post-tetanus. Cells were monitored for membrane resistance and seal quality 
throughout. In NASPM LTP experiments, 20 µM NASPM was included in ACSF 
throughout. Whole-cell data was collected using a Digidata 1440 with Multiclamp 700B 
amplifier (Molecular Devices). Evoked experiments were conducted using a Model 2100 
Isolated Pulse Stimulator (A-M Systems). All data was acquired with pCLAMP software 
and analyzed in Clampfit.  
TF-488 feeding to label REs 
 DIV 14 neurons were transferred into Neurobasal with no additives and 
supplemented 0.1% BSA for 30 min at 37°C. Cells were incubated with Alexa 488 
labeled transferrin (TF-488) (Invitrogen) for 30 min at 37°C and then processed for 
fixation and immunocytochemistry (rabbit anti-AKAP150 1:1000, followed by goat anti-
rabbit-Alexa 568 1:1000). TF-488 (final concentration of 5 µg/well) was 
microcentrofuged at max speed for 1 min prior to application and only the supernatant 
was added to cells to prevent aggregation. Imaging was carried out on an Axio 
Observer microscope (Zeiss) with a 63× Plan Apo/1.4 NA objective using 488 and 561 
nm laser excitation and a CSU-XI spinning-disk confocal scan head (Yokogawa) 
coupled to an Evolve 512 EM-CCD camera (Photometrics) driven by SlideBook 6.0 
(Intelligent Imaging Innovations). Z-stacks of 13 optical sections (0.33 µm each) were 
acquired. Data was analyzed with SlideBook 6.0 using single optical sections of in-focus 
TF-488 signal. Masks were drawn over in-focus dendritic segments and only single- 




SEP-TfR imaging  
Imaging of super-ecliptic pHluorin-tagged transferrin receptor was conducted 
essentially as previously described247,248. DIV 11-14 hippocampal neurons from WT and 
AKAP150 CS mouse cultures were transfected (Lipofectamine 2000) with plasmids 
encoding SEP-TfR and mCherry (as a cell fill) and imaged 3 days later. Imaging was 
conducted on the spinning-disk confocal microscope detailed above. Prior to imaging, 
neurons were incubated in ACSF plus 1 mM MgCl2 for 30 min and were maintained 
during imaging at 33−35°C in a perfusion chamber (Warner Instruments). Baseline rates 
of SEP-TfR exocytic events (events defined as 2.5-fold above the median intensity of 
the dendrite) were determined by acquiring z-stacks of 10 optical sections (1.0 µm 
spacing) every 6 s for 5 min.  
Immunocytochemistry on mouse primary hippocampal neuron cultures for 
dendritic spine analysis  
For dendritic spine counting in cultured hippocampal neurons, DIV12-14 neurons 
were transfected with a plasmid encoding GFP using Lipofectamine 2000 (Invitrogen) 
and fixed after two days of expression on DIV14-16. Neurons were washed with ACSF 
(in mM: 130 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 20 Glucose) x 2, then fixed in 
4% paraformaldehyde (PFA), permeabilized in 0.1% Triton X-100 in PBS, and blocked 
overnight in a 5% BSA/PBS solution. Primary anti- GFP antibodies were incubated for 
2h at room temperature in 5% BSA/PBS. Cells were then washed in PBS and incubated 
in secondary antibody conjugated to Alexa 488 for 1h at room temperature. Coverslips 
were washed in PBS and mounted onto glass slides with Pro-Long Gold (Invitrogen). 




xenon lamp (Sutter), 63xPlan- Apo/1.4 NA objective, FITC/Alexa 488, Cy3/Texas Red 
and Cy5/Alexa 647 filter sets (Chroma), Coolsnap CCD camera, and Slidebook 5.0 
software. Three-dimensional z-stacks with 0.33 µm steps were collected. Spines were 
counted from 50-100 µm segments of secondary or higher-order dendrites in Slidebook 
6.0 (3 individual neuron preps, 2-3 coverslips per prep per genotype).  
Dendritic spine analysis by DiI labeling 
 Slices were prepared as for whole-cell electrophysiology (300 µm on a 
Vibratome). Slices were fixed in 4% PFA overnight at 4°C, washed in PBS 3 x 15 min. 
After washing, sonicated DiI powder was collected on the tip of a needle and gently 
placed on the CA1 region of the hippocampus366. DiI was allowed to incorporate 
overnight at room temperature. Slices were washed in PBS 3x15 min and then mounted 
onto glass slides using Vectashield (Vector Laboratories). Slices were imaged via 
spinning-disk confocal microscopy as detailed above. Spines were counted from for 50-
100 µm segments of secondary or higher-order dendrites in ImageJ (NIH) (< 3 neurons 
per slice were counted, 2-3 slices/animal, 3 animals per genotype).  
Surface GluA1 antibody labeling  
DIV 14-16 neurons plated on #1.5 glass coverslips were transferred to ACSF 
with 1 mM Mg2+ for 30 min. Cells were transferred to ACSF for 30 min then rabbit anti-
GluA1 antibody (Millipore 1:250) was live-fed for 15 min at 37°C before being washed in 
ice-cold ACSF 2x and fixed in 4% PFA. Cells were then processed for STED imaging by 
labeling with mouse anti-PSD-95 primary antibodies and fluorescent secondary 




Super-resolution stimulated emission depletion (STED) nanoscopy  
Neurons plated on #1.5 glass coverslips were washed 2x ACSF then fixed with 
4% PFA for 10 min. Coverslips were washed 3x5 min with PBS with rotation and then 
permeabilized with 0.1% Triton. Neurons were next washed 3x5 min with PBS and then 
blocked overnight with filter-sterilized 5% BSA/PBS. Neurons were incubated with 
primary antibody in 5% BSA/PBS at room temperature (rabbit anti-AKAP150 1:1000, 
mouse anti-PSD-95 1:500), then washed 3x5 min PBS and incubated at room 
temperature for 1 h with secondary antibodies (goat anti-rabbit-Atto 647N 1:500 and 
goat anti-mouse-Atto 594 1:500; Rockland). Images were acquired on a custom built 
STED microscope367. Custom ordered 40 nm beads (Life Technologies) labeled with 
red and far-red dyes (proprietary) were used for resolution measurement and system 
alignment.  
STED image analysis 
The methodology of image segmentation and geometric analysis applied to 
STED images here will be described in more detail elsewhere along with its application 
to 3D-structured illumination microscopy (SIM) images368. Briefly, a Split-Bregman 
image segmentation algorithm first described in369 and subsequently incorporated into 
the MOSAIC image processing suite for ImageJ/FIJI (http://mosaic.mpi-cbg.de/)370 was 
utilized to delineate object boundaries from background-corrected STED images (using 
a histogram-based background estimator, also implemented as part of the MOSAIC 
suite). Binary masks generated in this process were then imported into MATLAB 
(Mathworks) where the geometric properties of the defined objects were calculated. 




Table 3.1: Key resources table 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Polyclonal rabbit anti-AKAP 150 Brandao et al., 2012  RRID: AB_2532138  
Monoclonal mouse anti-PKA-RII β BD Transduction 
Laboratories 
Cat# 610625, RRID: 
AB_397957 
Monoclonal mouse anti-PSD95  Millipore  Cat# MAB1596; RRID: 
AB_2092365  
Polyclonal rabbit anti-GluR1 Millipore Cat# ABN241; RRID: 
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Quantification and statistical analysis 
Data compilation and statistical analysis were performed in Prism (GraphPad) 
with significance value as α=0.05. All data are reported as mean ± SEM. Prism provides 
exact p-values unless p < 0.0001. The statistical tests used, p-values and replicates 
with definition of n for all experiments can be found in the figure legends. No tests were 
used to estimate sample size. All experiments, except the initial APEGS assay in 
Fig.1B, were performed at least 3 separate times (or on at least 3 separate animals) to 
ensure rigor and reproducibility. Both male and female mice were used for 
electrophysiology experiments, and we observed no differences between sexes, 
therefore data from both sexes were pooled for all experiments.  
Results 
AKAP CS palmitoylation-deficient knock-in mice exhibit reduced AKAP150 levels 
in PSD-enriched fractions.  
To study the impacts of loss of AKAP150 palmitoylation, we generated a 
palmitoylation-deficient AKAP150 mouse (AKAP CS) (Fig 3.1A) using a piggyBac 
transposon-based ES cell targeting vector strategy to introduce mutations into the 
mouse Akap5 gene locus (Fig 3.2A). The resulting Akap5CS mutant allele replaces Cys 
at positions 36 and 123 with Ser (Figs 3.1A&3.2A), while simultaneously introducing a 
HindIII site to facilitate genotyping (Fig 3.2B). AKAP CS mice are viable and are visibly 
indistinguishable from their WT littermates, with no apparent physical deficits or 
changes in overall brain anatomy (not shown). In addition, we observed no changes in 






Figure 3.1: AKAP150 and PKA-RII levels are reduced in PSD-enriched fractions 
from AKAP CS palmitoylation-deficient mice.  
(A) Schematic of AKAP150 highlighting binding partners and functional domains. 
AKAP150 is palmitoylated at Cys 36 and 123, and these residues are mutated to Ser to 
create the AKAP CS palmitoylation-deficient mutant mouse.  (B) APEGS assay showing 
that AKAP150 WT, but not CS, is palmitoylated in lysates from mouse brain. (C) 
Subcellular fractionation and western blotting from WT and CS P21 mouse 
hippocampus for AKAP150, PSD-95, and PKA-RIIβ. P2, crude synaptosomes; S2, 
cytosol and light membranes; TxP, triton-insoluble sub-fraction of P2 = PSD-enriched 
fraction; TxS, triton-soluble sub-fraction of P2; WE, whole extract. (D–F) Quantification 
of subcellular fractionation from (C) normalized to WT WE levels showing (D) decreased 
AKAP150 protein levels in P2 and TxP fractions from CS mice (P2: WT 1.36 ± 0.14, CS 
0.44 ± 0.16, unpaired t test **p = 0.0033; TxP: WT 1.00 ± 0.10, CS 0.17 ± 0.05, 
unpaired t test ***p = 0.00028; WT n = 5, CS n = 4), (E) decreased PKA-RIIβ protein 
levels in TxP fractions from CS mice (WT 0.44 ± 0.063, CS = 0.22 ± 0.029, unpaired t 
test *p = 0.036; n = 3), but (F) no change in fractionation of PSD-95 in CS versus WT 
mice. (G) AKAP150 APEGS assay of subcellular fractions from WT mouse forebrain. 
(H) Quantification of the proportion of AKAP150 in the unpalmitoylated lower MW band 
and the mono- and di-palmitoylated higher MW bands across the subcellular fractions in 
(G).  (I) Quantification of the total proportion of palmitoylated AKAP150 (mono- plus di-) 
revealing significantly more palmitoylated AKAP150 in P2 versus S2 and TxP versus 
TxS (S2 0.26 ± 0.16, P2 0.63 ± 0.065, unpaired t test *p = 0.022; TxS 0.56 ± 0.059, TxP 
0.73 ± 0.062, unpaired t test *p = 0.028; n = 3).  *p < 0.05, **p < 0.01, and ***p < 0.001 






Figure 3.2:  Additional characterization of AKAP CS mice and cultured neurons.  
(A) Generation of AKAP CS mice using the Piggybac method, introducing two point 
mutations and a HindIII site. (B) Genotyping by PCR and restriction digestion of 
AKAP150 WT and AKAP150 CS heterozygous and heterozygotes; HindIII digestion 
results in AKAP150 CS specific fragments. (C) Dendritic segments from neurons in 
region CA1 of the hippocampus from WT or AKAP CS DiI stained slices, showing no 
significant difference in (D) spine number or (E) spine head area. (F) DIV14-16 
hippocampal cultures transfected with GFP, show no significant difference in (G) spine 












 (Fig 3.2C-E) or in cultured hippocampal neurons prepared from CS compared to WT 
mice (Fig 3.2F-H). To confirm loss of AKAP150 palmitoylation in CS mice, we employed 
an APEGS (Acyl-PEGyl Exchange Gel-Shift) assay of palmitoylation that exchanges 
palmitates for polyethylene glycol polymers to produce upward molecular weight 
shifts265,306. Using this APEGS assay we detected mono- and di-palmitoylated AKAP in 
whole brain extracts of WT but not CS mice, where only unpalmitoylated 150 kDa AKAP 
was detected (Fig 3.1B).  
Previous biochemical and imaging studies indicate that AKAP79/150 associates 
with membrane lipids, including in lipid rafts, and other post-synaptic proteins, including 
PSD-95 and F-actin, and is localized not only in the PSD but also the extrasynaptic 
membrane245,247,249,255,267,363. To explore the effect of eliminating AKAP palmitoylation on 
its synaptic localization in vivo, we used differential centrifugation and detergent 
extraction104,275,363,364 to isolate subcellular fractions from hippocampal lysates of 2-3 
week-old mice followed by immunoblotting (Fig 3.1C). Intriguingly, we observed a 
selective decrease in AKAP150 CS protein compared to WT in the synaptosomal 
membrane fraction (P2) and a PSD-enriched fraction (TxP) derived from P2 by Triton X- 
100 detergent extraction (Fig 3.1C,D). An accompanying decrease in PKA-RII 
regulatory subunits was also seen in TxP for CS mice (Fig 3.1E). The distribution of 
PSD-95 across these fractions was not significantly different between WT and CS mice 
with its highest levels detected in the TxP/PSD-enriched fraction as expected; however, 
we did observe a non-significant trend toward slightly increased PSD-95 levels in TxP 
for CS (Fig 3.1F). Overall, these fractionation data suggest that AKAP150 CS is less 




normally promotes AKAP150 localization in the PSD. Consistent with this idea, we 
combined subcellular fractionation with the APEGS palmitoylation assay in WT mice 
(Fig 3.1G) to reveal significant enrichment of palmitoylated AKAP150 in P2 relative to 
the S2 fractions and TxP relative to TxS fractions (Fig 3.1H,I). In particular, while 
unpalmitoylated AKAP150 predominates in whole extracts and the cytosolic/S2 fraction, 
mono- plus di- palmitoylated AKAP150 constitute the majority in synaptosomal/P2, 
perisynaptic/TxS, and PSD-enriched/TxP fractions, the latter of which contains the 
highest overall proportion of palmitoylated AKAP150 (Fig3.1H,I).  
AKAP CS dendritic spines contain smaller AKAP150 nanodomains that exhibit 
reduced overlap with the PSD.  
Due to the submicron dimensions of dendritic spines and organization of the PSD 
into even smaller nanodomains on the scale of ~100 nm7,78,79,184, we reasoned that any 
changes in AKAP150 CS post-synaptic localization may be below the diffraction-limited 
resolution of standard confocal microscopy (~250 nm). Indeed, previous studies using 
standard microscopy revealed no differences in basal spine localization of GFP-tagged 
AKAP79 WT vs. CS in transfected neurons247. We therefore employed a custom-built, 
two-color Stimulated Emission Depletion (STED) nanoscope with a resolution of ~40-60 
nm367 to assess the localization of AKAP150 relative to PSD-95 in dendritic spines of 
hippocampal neurons cultured from WT and CS mice (Fig 3.3). In agreement with our 
previous work on AKAP79 CS-GFP, standard confocal imaging revealed that AKAP150 
CS and WT are both localized to dendritic spines and show substantial overlap with 





Figure 3.3: AKAP150 CS localization to the PSD is reduced.  
(A and B) Confocal and STED imaging (A) and associated segmentation object masks 
(B) for 14–16 day in vitro (DIV) 14–16 hippocampal cultures from WT and CS mice 
stained for AKAP150 (red) and PSD-95 (green). STED images show enhanced 
resolution and provide better sub-synaptic visualization of AKAP150 localization relative 
to the PSD.  (C–F) Significant decrease in AKAP object area in AKAP CS cultures (C) 
(WT 0.01961 ± 0.0009 µm2, n = 102 spines; CS 0.01614 ± 0.0007 µm2, n = 106 spines; 
unpaired t test **p = 0.0043) that was accompanied by decreases in (D) AKAP object 
major-axis length (WT 0.205 ± 0.006 µm, CS 0.1874 ± 0.006 µm, unpaired t test *p = 
0.0344), (E) total AKAP perimeter (WT 0.5585 ± 0.017 µm, CS 0.5034 ± 0.014 µm, *p = 
0.0104), and (F) AKAP compartment area within spines (WT 0.9372 ± 0.019 µm2, CS 
0.8662 ± 0.019 µm2, unpaired t test *p = 0.0104). (G and H) No change is seen in AKAP 
object number per spine (G), but (H) AKAP CS PSD localization is reduced, as 
indicated by a decrease in AKAP and PSD-95 object overlap (WT 0.2971 ± 0.01, CS 
0.2474 ± 0.01, **p = 0.0058).  *p < 0.05 and **p < 0.01 by unpaired t test. Data are 









AKAP150 clusters for both WT and CS that were not visible in confocal images and 
were located overlapping the PSD, closely surrounding the PSD, and also in distinct 
locations outside the PSD (Fig 3.3A,B). This ability of STED to resolve distinct 
extrasynaptic, perisynaptic and PSD clusters of AKAP150 that are not visible in 
standard confocal imaging parallels findings for AMPARs using STED and 
STORM/PALM that revealed previously unappreciated nanodomain 
organization7,78,79,184 (see also Fig 3.7). Using a custom, object-based image 
segmentation mask analysis method (Fig 3.3B) that we recently developed for intensity-
based super-resolution imaging methods (i.e. STED, see STAR Methods) we found that 
the area (Fig 3.3C) and major axis length of individual AKAP150 objects (Fig 3.3D) in 
spines were both significantly reduced for the CS mutant compared to WT. 
Correspondingly, the total perimeter (Fig 3.3E) and area occupied by AKAP150 objects 
within spines (Fig 3.3F) were both significantly reduced for CS but with no changes in 
the average number of AKAP objects per spine (Fig 3.3G). Importantly, the proportional 
spatial overlap of AKAP150 and PSD-95 objects was also decreased for CS (Fig 3.3H) 
despite a small increase in total PSD area in spines (see Fig 3.7L below). Collectively, 
these STED imaging data are in agreement with the fractionation data presented above 
and indicate that AKAP150 CS localization in and around the PSD is reduced.  
AKAP CS localization to recycling endosomes is decreased.  
In previous work, we found that AKAP palmitoylation also controls targeting to 
REs. In addition, we observed that acute disruption of AKAP79/150 palmitoylation in rat 
hippocampal cultures resulted in enhanced basal RE fusion events in neuronal 




marked by live-cell feeding with Alexa-488 labeled transferrin (TF-488) and also 
monitored basal exocytosis of transferrin receptor (TfR)-positive REs by expressing 
super-ecliptic pHluorin-tagged TfR (SEP-TfR) in WT and CS mouse dissociated 
hippocampal cultures (Fig 3.4). Consistent with previous work on human AKAP79, 
AKAP150 robustly co-localized with TF-488 positive puncta in WT mouse neurons but 
showed a significant decrease in RE localization in CS neurons  (Fig 3.4A,B). Contrary 
to our previous findings showing that acute AKAP79 CS overexpression increased 
basal RE exocytosis, basal RE exocytosis imaged with SEP-TfR was not significantly 
different in CS compared to WT mouse neurons; although a slight non-significant trend 
toward increased exocytosis was observed (Fig 3.4C,D). Collectively, these data 
suggest that RE exocytosis (as read out by TfR recycling) is largely normal in CS mice 
despite decreased AKAP150 localization to REs.  
AKAP CS mice exhibit enhanced CP-AMPAR-mediated basal synaptic 
transmission.  
Given that we observed reduced AKAP150 association with both REs and the 
PSD in CS mice, we wanted to explore how synaptic transmission and plasticity might 
be impacted. To start, we characterized basal synaptic transmission at CA1 synapses in 
acute, ex vivo hippocampal slices from 2-3 week-old WT and CS mice by whole-cell 
voltage-clamp recording of AMPAR-mediated miniature and spontaneous excitatory 
post-synaptic currents (mEPSCs and sEPSCs). Compared to WT, CS mice showed 
slightly enhanced mean mEPSC amplitude, slightly decreased mean mEPSC frequency 







Figure 3.4: AKAP150 CS endosome localization and RE exocytosis.   
(A) Max projection images of DIV14 WT or AKAP150 CS neurons labeled with 
Alexa488-transferrin (TF-488) to mark REs and endogenous AKAP150. (B) AKAP CS 
neurons show a significant decrease in AKAP co-localization with the RE marker 
transferrin. (C) Time composite (5 min, 0.2 Hz) images of 15-17 DIV hippocampal 
neurons from WT or AKAP150 CS mice showing RE exocytic events in dendrites 
imaged with SEP-TfR with integrated intensity plotted on the z-axis (pseudocolor: blue, 
low; red, high).  (D) No significant difference between genotypes was detected in the 
number of exocytic events (defined as 2.5-fold the median fluorescence intensity) 












amplitudes and inter-event intervals (Fig 3.5B). A similar decrease in sEPSC frequency 
and a non-significant trend toward increased sEPSC amplitude was observed in CS 
compared to WT (Fig 3.5C,D). Cultured hippocampal neurons from AKAP CS mice also 
exhibited slightly increased mEPSC amplitude (Fig 3.6A,B) but with no change in 
frequency (Fig 3.6A,C). Decreased mEPSC/sEPSC frequency could indicate a 
reduction in pre-synaptic release probability or a reduction in the overall number of 
synapses; however, analysis of CA1 dendritic spine numbers above revealed no 
differences between WT and CS (Fig 3.2C). We tested for changes in pre-synaptic 
release probability by measuring evoked AMPAR-mediated paired-pulse ratios (PPR) at 
Schaffer collateral (SC) synapses. We observed no differences in PPR between WT 
and CS in either whole-cell -70 mV EPSC (Fig 3.5E) or extracellular field excitatory 
post-synaptic potential (fEPSP) recordings (Fig 3.5G), thus indicating normal pre-
synaptic function in CS mice. Furthermore, input-output curves for evoked AMPAR 
EPSC amplitude (Fig 3.5F) and fEPSP slope (Fig 3.5H) were similar for WT and CS.  
A normal evoked SC-CA1 input-output relationship for CS mice indicates that basal 
AMPAR-mediated synaptic strength is largely unaffected despite somewhat decreased 
frequency of spontaneous transmission. However, the small increase in mEPSC 
amplitude could reflect a change in AMPAR subunit composition related to synaptic 
incorporation of higher-conductance GluA2-lacking CP-AMPARs. Consistent with 
possible incorporation of CP-AMPARs at SC-CA1 synapses in CS mice, the ratio of 
evoked inward -70 mV AMPA peak current to outward +40 mV NMDA current 
(measured 50 ms after peak) was increased in CS mice relative to the corresponding 





Figure 3.5: AKAP CS mice exhibit slightly increased AMPAR mEPSC amplitude 
and decreased frequency but normal evoked basal transmission at hippocampal 
CA1 synapses. 
(A and B) Representative traces for mEPSC recordings with plots of mean amplitude 
and frequency (A) and cumulative distribution plots of mEPSC amplitude and inter-
event interval (B) for CA1 neurons in acute hippocampal slices from WT and AKAP CS 
mice showing a slight increase in mEPSC amplitude and a slight decrease in mEPSC 
frequency (A: mEPSC amplitude: WT = 6.79 ± 0.371 pA n = 29 cells, CS = 7.883 ± 
0.251 pA n = 35 cells, unpaired t test *p = 0.0145; mEPSC frequency: WT = 0.72 ± 
0.059 Hz, CS = 0.57 ± 0.042, unpaired t test *p = 0.0475). (C and D) Representative 
traces for sEPSC recording with plots of mean amplitude and frequency (C) and 
cumulative distribution plots of sEPSC amplitude and inter-event interval (D) for WT and 
CS mice showing a slight but not significant increase in sEPSC amplitude and a 
significant decrease in sEPSC frequency for CS mice (C: sEPSC frequency: WT 2.21 ± 
0.297 Hz, n = 19 cells; CS 1.02 ± 0.0862 Hz, n = 24 cells; unpaired t test ***p = 0.0001). 
 (E–H) No changes in SC-CA1 evoked basal AMPAR transmission are observed for CS 
mice in (E and G) paired-pulse ratios or (F and H) input-output curves in either whole-
cell EPSC or extracellular fEPSP recordings. *p < 0.05 and ***p < 0.001 by unpaired t 





Figure 3.6:  Electrophysiological characterization of AKAP CS cultures. 
(A-C) Whole-cell recordings from DIV13-14 hippocampal neuron cultures from WT and 
CS mice. AKAP CS cultures show an enhancement in (B) mEPSC amplitude 
(WT=19.34 ± 1.599 n=17 cells, CS=23.86 ± 1.434 n=16, unpaired t-test p=0.0443) and 
no change in (C) mEPSC frequency. (D-H) AKAP CS neuron cultures also exhibit 
enhancement in CP-AMPAR sensitivity, showing a significant decrease in mEPSC 
amplitude with IEM blockade of CP-AMPARs (CS=23.86 ± 1.434 pA n=16, CS 











presence of inwardly-rectifying CP-AMPARs in CS mice. Yet, increased AMPA/NMDA 
ratios can arise not only from enhanced AMPAR function but also from decreased 
NMDAR function. However, the input-output relationship for evoked NMDAR EPSCs 
revealed no significant differences in basal NMDAR transmission between CS and WT 
mice, with if anything a trend toward increased NMDAR function in CS (Fig 3.7B).   
Taken together, these data suggest that the increases in mEPSC amplitude and 
AMPA/NMDA ratio observed in CS mice may be attributable to synaptic CP-AMPARs.  
To directly test whether synaptic AMPAR subunit composition is different in CS mice, 
we utilized two approaches. First, we determined the current/voltage (I/V) relationship 
for AMPAR EPSCs over a range of holding potentials from -70 to +40mV. CP-AMPARs 
exhibit inward-rectification due to block of outward current by intracellular polyamines. 
As expected, WT mice displayed a linear AMPA EPSC I/V relationship, which is 
characteristic of GluA2-containing AMPARs. By contrast, SC-CA1 transmission in CS 
mice exhibited an inward-rectifying AMPA I/V relationship, which is indicative of GluA2-
lacking CP-AMPARs (Fig 3.7C). Inward-rectification in CS mice was also quantified as a 
significantly enhanced -70mV/+40mV AMPA EPSC rectification index (Fig 3.7D). 
Second, we applied NASPM, an extracellular polyamine, which selectively blocks 
inward current mediated by CP-AMPARs. Consistent with CS mice containing a greater 
number of synaptic CP-AMPARs, application of NASPM blocked ~40% of the inward 
AMPA EPSC in CS but not WT mice (Fig 3.7E). Furthermore, while mEPSC amplitude 
and frequency measured in WT mouse cultured hippocampal neurons were insensitive 




CS cultured neurons was inhibited/reversed by IEM1460 application with no impact on 
frequency (Fig 3.6D-H).  
Finally, STED imaging and object-based segmentation analysis of surface GluA1 
(sGluA1) and PSD-95 antibody staining (Fig 3.7F) revealed an increase in sGluA1 
object area (Fig 3.7G) and major axis length (Fig 3.7H) but with no change in the 
average number of sGluA1 objects per spine for CS compared to WT (Fig 3.7I). 
However, the total perimeter (Fig 3.7J) and area occupied by sGluA1 objects (Fig 3.7K) 
were both increased for CS. In addition, increased sGluA1 clustering in CS neurons was 
also accompanied by an increase in total area occupied by PSD-95 objects in spines 
(Fig 3.7L), perhaps explaining why the proportional overlap of sGluA1 with PSD-95  
remained similar between CS and WT (Fig 3.7M). Overall, these sGluA1 STED imaging 
results are consistent with increased post-synaptic GluA1 expression in CS cultured 
neurons and increased basal CP-AMPAR activity measured by electrophysiology.  
Previous work found that phosphorylation of GluA1 S845 by AKAP150-anchored 
PKA promotes and dephosphorylation by AKAP150-anchored CaN restricts CP-AMPAR 
synaptic incorporation103,104,275,354. However, immunoblotting analysis of hippocampal 
subcellular fractions (Fig 3.8A) revealed no significant differences between WT and CS 
in either total GluA1 expression (Fig 3.8B) or pS845 levels, although non-significant 
trends toward increased pS845 were observed across all fractions in CS mice (Fig 
3.8C). Overall, these data indicate that hippocampal neurons from CS mice have 
increased basal GluA1 CP-AMPAR synaptic activity; however, given the high single- 
channel conductance of these receptors, synaptic insertion of a relatively small number 

















Figure 3.7: AKAP CS mice have elevated basal CP-AMPAR activity at CA1 
synapses.  
(A) Evoked SC-CA1 AMPA/NMDA EPSC ratios from WT and CS slices; AKAP CS mice 
show a substantial increase in -70 mV peak AMPA to +40 mV 50 ms after peak NMDA 
tail EPSC ratio and a smaller increase in the mixed AMPA and NMDA +40 mV peak to 
+40 mV 50 ms after peak NMDA tail EPSC ratio (-70 mV/+40 mV: WT 0.88 ± 0.080, n = 
9 cells, CS 1.43 ± 0.15, n = 8 cells, unpaired t test **p = 0.0052; +40 mV: WT 1.26 ± 
0.036, CS 1.46 ± 0.040, unpaired t test **p = 0.0017). (B) No change in evoked NMDA 
+40 mV EPSC input-output (I-O) relationship in AKAP CS. (C and D) Normalized AMPA 
EPSC I-V curve showing (C) decreased outward current at positive potentials (AMPA I-
V at +40 mV: WT 0.73 ± 0.093, n = 10 cells; CS 0.45 ± 0.059, n = 9 cells; unpaired t test 
*p = 0.0251; normalized to -70 mV EPSC amplitude) and (D) increased -70 mV/+40 mV 
EPSC amplitude rectification index (RI: WT 1.30 ± 0.121, n = 21; CS 2.12 ± 0.187, n = 
19; unpaired t test ***p = 0.0006) in AKAP CS slices. (E) Inhibition of -70 mV AMPA 
EPSC amplitude in AKAP CS but not WT slices by 20 µM CP-AMPAR blocker NASPM 
(WT 0.065 ± 0.042, n = 8 cells, CS -0.39 ± 0.084, n = 5 cells; unpaired t test ***p = 
0.0002; fold change baseline after NASPM application). (F–I) STED imaging of cultured 
hippocampal neurons stained for surface GluA1 (sGluA1) and PSD-95 (F) showing for 
AKAP CS neurons (G) increased sGluA1 object area (WT 0.02202 ± 0.00014 µm2, n = 
125 spines; CS 0.02835 ± 0.00015 µm2, n = 170 spines; unpaired t test **p = 0.0032) 
with (H) an increase in GluA1 object major-axis length (WT 0.19 ± 0.0067 µm, CS 
0.2132 ± 0.0064 µm, *p = 0.0132) but with (I) no change in object number. (J and K) 
AKAP CS spines also have increased total perimeter (J) (WT 0.5472 ± 0.02 µm, CS 
0.6252 ± 0.02 µm, **p = 0.0070) and (K) area occupied by sGluA1 staining in spines 
(WT 0.4571 ± 0.019 µm2, CS 0.5111 ± 0.016 µm2, *p = 0.0359). (L and M) The total 
area occupied by PSD-95 in spines is also increased in AKAP CS compared with WT 
(L) (WT 0.5056 ± 0.021 µm2, CS 0.5899 ± 0.016 µm2, **p = 0.0013) but with (M) no 
change in PSD-95 overlap with sGluA1.*p < 0.05, **p < 0.01, and ***p < 0.001 by 






















Figure 3.8: Analysis of GluA1 S845 phosphorylation.  
(A) Blots from fractionation of WT and CS hippocampal lysates probed for pS845 GluA1 
and GluA1 and (B,C) quantification of these blots showing no significant difference in 
total GluA1 protein or S845 phosphorylation although trends toward increased S845 





Since the majority of AMPARs in CA1 are GluA1/2 heteromers16, it would be very 
difficult to biochemically detect increased pS845 phosphorylation occurring in a small 
pool of CP-AMPARs in CS mice.  
AKAP150 palmitoylation is required for expression of CP-AMPAR-dependent but 
not CP-AMPAR-independent LTP.  
Our previous work found that AKAP150-anchored PKA and CaN modulate LTP 
and LTD at CA1 synapses through opposing each other in control of CP-AMPAR 
synaptic incorporation; however, the dependence of LTP on PKA signaling and AMPAR 
subunit composition is very flexible and developmentally plastic in mice between 2 and 
8 weeks of age103,104,125,133,175,179,371. In addition, CP-AMPAR synaptic recruitment during 
LTP could be affected by the strength and type of induction stimulus, which is another 
major variable across previous studies36,103,122,129,131,179,371. Due to these factors, the 
contributions of GluA1 and CP-AMPARs to CA1 LTP remain unclear and 
controversial104,125,133. Therefore, we next examined how loss of AKAP150 
palmitoylation impacts LTP and LTD at CA1 synapses in 2-3 week-old mice. A standard 
1x100 Hz, 1 s high frequency stimulus (HFS) protocol elicited reliable LTP of fEPSP 
slope (~150%) in WT slices, but failed to induce significant LTP in CS slices (Fig 
3.9A,E). In contrast, LTD induced with prolonged low-frequency stimulation (LFS; 1Hz, 
900 pulses, 15 min) was comparable (~60%) at CA1 synapses in WT and CS mice (Fig 
3.9B,F).  
To explore whether the LTP-deficit in CS mice relates to altered CP-AMPAR 
regulation, we used two different common whole-cell pairing LTP induction protocols 




particular, we found that brief 2x100 Hz, 1 s stimulation, which is similar to HFS 
induction of LTP in fEPSP experiments, paired with 0 mV post-synaptic 
depolarization146,147 induced substantial LTP in WT (~200%) that was strongly impaired 
in CS slices and inhibited by NASPM in WT slices (Fig 3.9C,G). In contrast, LTP was 
similar and much greater in magnitude (~325%) for both CS and WT mice when 
induced with a stronger, prolonged pairing protocol (3 Hz, 90 s, 0 mV)129,179,371 that was 
largely insensitive to NASPM in WT slices (Fig 3.9D,H). These results indicate that the 
LTP deficits in CS mice are specifically related to impaired CP-AMPAR regulation and 
also suggest that high-conductance CP-AMPARs are more important for expression of 
the lower levels of LTP induced with weaker stimuli versus higher levels of LTP induced 
with stronger stimuli, which robustly recruit GluA2-containing AMPARs.  
AKAP CS mice exhibit enhanced, CP-AMPAR-dependent de-depression after prior 
induction of LTD.  
While the enhancement in basal AMPAR transmission is modest in CS mice and 
a strong pairing induction stimulus can overcome the LTP deficit, we wanted to examine 
whether prior basal CP-AMPAR incorporation in CS mice was altering meta-plasticity to 
prevent additional CP-AMPAR recruitment in response to HFS. Our previous studies 
found that AKAP-CaN-dependent removal of CP-AMPARs from CA1 synapses is 
required during LTD104,275. Thus, having demonstrated that LTD is comparable to WT in 
CS mice (Fig 3.9B), we wondered whether prior induction of LTD to remove a proportion 
of existing synaptic AMPARs might allow CP-AMPAR recruitment in response to 
subsequent LTP induction resulting in de-depression. With this in mind, we induced LTD 














Figure 3.9: CP-AMPAR-dependent LTP at CA1 synapses is impaired in AKAP CS 
mice.  
(A and E) SC-CA1 fEPSP slope (normalized to baseline) recorded over time for WT and 
AKAP CS slices (A) and aggregate data for measurements of normalized fEPSP slope 
(E) (averaged over the last 10 min) showing robust 1x100 Hz 1 sec HFS induction of 
LTP in WT (~150%) that is significantly impaired in CS (A: ****p < 0.0001 by 2-way 
ANOVA over last 10 min; E: fEPSP slope for WT = 141.9 ± 4.55% n = 7 slices, CS = 
110 ± 12.04% n = 7 slices, unpaired t test last 10 min *p = 0.028). (B and F) SC-CA1 
fEPSP slope (normalized to baseline) recorded over time for WT and AKAP CS slices 
(B) and aggregate data for measurements of normalized fEPSP slope (F) (averaged 
over the last 10 min of recording) showing 1 Hz, 900 pulses (15 min) robust induction of 
LTD (~60%) in both WT and CS. (C and G) Normalized EPSC amplitude (normalized to 
baseline) recorded over time (C) and aggregate data for measurements of normalized 
EPSC amplitude (G) (averaged over the last 10 min) showing CP-AMPAR dependent, 
NASPM-sensitive LTP induced by 2x100 Hz, 1 s HFS, 0 mV pairing in WT slices is 
impaired in AKAP CS slices (C: 2-way ANOVA with Tukey’s multiple comparisons test 
for last 10 min: WT NASPM versus WT ****p < 0.0001, WT versus CS ****p < 0.0001; 
G: WT = 204.9 ± 3.24% n = 5 cells, CS = 133.8 ± 9.41% n = 6 cells, WT NASPM = 
119.6 ± 22.45% n = 5 cells; unpaired t test WT versus WT NASPM *p = 0.0113, WT 
versus CS *p = 0.0362). (D and H) Normalized EPSC amplitude (normalized to 
baseline) recorded over time (D) and aggregate data for measurements of normalized 
EPSC amplitude (H) (averaged over the last 10 min) showing CP-AMPAR independent, 
NASPM insensitive LTP induced by 3 Hz, 90 s, 0 mV pairing in WT slices is normal in 
CS slices (H: WT = 337.4 ± 44.25% n = 6 cells, WT NASPM = 305.6 ± 51.8% n = 4 





















induce LTP/de-depression. As seen in previous studies164,372, HFS-induced de-
depression in WT slices returned fEPSP responses back to pre-LFS baseline values 
within 30 min of induction (Fig 3.10A). In CS slices, not only did we observe HFS-
induced de-depression, but this de- depression was also greater than that observed in 
WT. In addition, while NASPM had no significant impact on in WT slices, it reduced de-
depression in CS slices to WT levels (Fig 3.10A,B). Thus, the basal increase in CP-
AMPAR synaptic activity in CS mice is altering the ability of CA1 synapses to undergo 
LTP and prior removal of synaptic AMPARs by LTD can restore LTP responsiveness by 
allowing subsequent CP-AMPAR recruitment.  
Summary and discussion 
Dynamic protein palmitoylation has emerged as a key regulator in the subcellular 
positioning of proteins in neurons to coordinate precise and specific signaling333,334. 
Here, using biochemistry, super-resolution nanoscopy and electrophysiology we 
demonstrate the importance of palmitoylation of the post-synaptic scaffolding molecule 
AKAP150 in controlling basal AMPAR synaptic subunit composition to alter LTP.  
Complete gene knockout is widely used to study the effect of disrupting protein 
function. However, for large, multivalent scaffold protein complexes that function as 
structural and signaling hubs, knockouts are problematic due to disruption of multiple 
functions. In particular, AKAP150 KO removes the opposing signaling functions of PKA 
and CaN, allowing compensation that makes mechanistic interpretations difficult. 
Accordingly, AKAP150 null mice exhibit different and in general more limited behavioral 
and synaptic phenotypes than AKAP150 knock-in mice that are specifically deficient in 







Figure 3.10: AKAP CS mice can undergo CP-AMPAR-dependent de-depression at 
CA1 synapses. 
(A and B) fEPSP slope (normalized to baseline) recorded over time (A) and aggregate 
data for measurements of normalized fEPSP slope (B) (averaged over last 10 min) 
showing that de-depression (induced by 1 Hz, 900 pulses LFS-LTD followed by 1x100 
Hz, 1 s HFS-LTP 15 min later) is enhanced in CS mice (A: over last 10 min CS versus 
WT ****p < 0.0001 by 2-way ANOVA with Tukey’s multiple comparisons; B: WT 96.27 ± 
8.537%, n = 7 slices, CS 111.8 ± 8.638%, n = 7 slices; unpaired t test CS versus WT 
***p = 0.0010). CS but not WT de-depression is sensitive to CP-AMPAR blockade with 
NASPM (A: over last 10 min CS NASPM versus CS ***p < 0.001, WT NASPM versus 
CS ****p < 0.0001 by 2-way ANOVA with Tukey’s multiple comparisons; B: WT NASPM 
85.42 ± 10.23%, n = 5 slices, CS NASPM 97.46 ± 8.487%, n = 8 slices; unpaired t tests 
WT NASPM versus WT p > 0.05 [n.s.], CS NASPM versus CS **p = 0.0016, WT 








Figure 3.11: Summary of findings from Chapter III.  
AKAP CS mice show increased mEPSC amplitude and have increased basal insertion 
of CP-AMPARs. Palmitoylation of AKAP controls AKAP synapse organization and 
occupancy, as well as AMPAR surface expression. AKAP CS mice show a selective 
disturbance in CP-AMPAR dependent LTP, while maintaining CP-AMPAR independent 





we generated palmitoylation-deficient AKAP CS knock-in mice to specifically address 
the role of palmitoylation in controlling AKAP150 post-synaptic targeting and AMPAR 
regulation (Fig 3.11). 
AKAP150 palmitoylation and PKA/CaN anchoring in control of basal CP-AMPAR 
incorporation  
Importantly, we observed a very specific synaptic phenotype in AKAP CS 
animals that is distinct from, but overlapping with, phenotypes observed in either AKAP-
PKA or -CaN anchoring-deficient mice. In particular, both CS and CaN anchoring-
deficient ΔPIX mice104,275 exhibit increased basal synaptic CP-AMPAR activity. 
However, despite ΔPIX mice exhibiting significantly enhanced GluA1 S845 
phosphorylation and stronger EPSC inward rectification than CS mice275, altered 
AMPAR subunit composition is only associated with increased mEPSC amplitude in CS 
mice. In addition, while blocking CP-AMPARs with IEM1460 in neurons cultured from 
WT mice had no impact on mEPSC activity, IEM1460 reduced basal mEPSC amplitude 
and frequency in ΔPIX mouse neurons to below WT levels354. Yet, in CS cultured 
neurons IEM1460 only reduced elevated mEPSC activity back to WT levels. Thus, in 
ΔPIX mice the impact of CP-AMPARs on basal synaptic strength is offset by an 
accompanying, compensatory loss of GluA2-containing receptors, but in CS mice, while 
a smaller number of CP-AMPARs are added to synapses, little or no compensatory 
removal of GluA2-containing receptors is occurring. Overall, the impacts of loss of 
AKAP palmitoylation on basal AMPAR transmission are similar but clearly not identical 




AKAP150 palmitoylation and PKA/CaN anchoring in CP-AMPAR meta-plasticity 
that controls LTP/LTD balance  
In contrast, the CA1 LTP phenotypes in CS and ΔPIX mice are drastically 
different, with ΔPIX mice showing strongly enhanced275 and CS mice exhibiting strongly 
impaired HFS-induced LTP. The relatively modest enhancement in basal AMPAR 
transmission in CS mice is unlikely to occlude LTP, and given our previous observations 
of enhanced CP-AMPAR-dependent LTP in ΔPIX mice, prior basal incorporation of CP-
AMPARs alone cannot account for impaired LTP in CS mice. However, a key difference 
between the plasticity landscapes of these two knock-in mice is the lack of LFS-induced 
LTD in ΔPIX but not CS mice. In ΔPIX mice, loss of AKAP-CaN anchoring impairs CP-
AMPAR removal from synapses to alter meta-plasticity at CA1 synapses in favor of LTP 
> LTD104,275. In contrast, in CS mice LTD and CP-AMPAR synaptic removal 
mechanisms appear to be intact, pointing more toward a specific deficit in recruitment of 
additional CP-AMPARs to support LTP. Indeed, we were able to further link the LTP 
deficit in CS mice specifically to CP-AMPAR dysfunction by showing that it could be 
overcome by using a strong, prolonged whole-cell pairing induction stimulus that did not 
require CP-AMPAR recruitment in WT mice. In addition, we were able to establish that 
elevated basal CP-AMPAR activity in CS mice was contributing to the inability of HFS to 
recruit additional CP-AMPARs by showing that prior LTD induction to remove synaptic 
AMPARs allowed subsequent HFS to induce LTP/de-depression that was in part 
mediated by CP-AMPARs. Thus, overall, loss of AKAP150 palmitoylation increases 
basal CP-AMPAR synaptic incorporation but impairs additional recruitment to alter CA1 




Interestingly, prior characterization of PKA anchoring-deficient AKAP150 knock- 
in mice also found deficits in LTP related to impaired CP-AMPAR recruitment, but only 
in adult (~8 week-old) and not juvenile (2-4 week-old) mice103,104. In particular, while 
HFS-induced LTP at ~2 weeks of age was strongly inhibited by CP-AMPAR antagonists 
in WT mice, LTP was neither impaired nor sensitive to CP-AMPAR antagonists in ΔPKA 
mice104. These studies, along with a number of other studies of CA1 LTP using GluA1 
knockout mice, S845A knock-in mice, and subunit replacement approaches, indicate 
the dependencies of LTP on PKA signaling, S845 phosphorylation, and AMPAR 
subunit-composition are flexible and developmentally plastic in juvenile 
animals36,122,125,129,167,171,172,175,179,371. Thus, it is remarkable that the compensatory shift 
to HFS-LTP recruitment of GluA2-containing AMPARs that is observed in juvenile 
GluA1 knockout, S845A, and AKAP150ΔPKA/D36 mice is not occurring in CS mice, 
where the LTP deficit can only be overcome by prolonged whole-cell pairing that 
recruits GluA2-containing AMPARs even in WT mice. Importantly, our present findings 
demonstrating that CP-AMPAR recruitment depends strongly on LTP induction stimulus 
strength in general agreement with previous observations made across several different 
ages103,131,179,371 and could explain discrepancies in previous studies of juvenile rodents 
that observed CP-AMPAR recruitment for LTP induced with comparatively 
weaker36,122,167 but not stronger pairing protocols129.  
Interestingly, at this same early developmental age when LTP is normal in ΔPKA, 
D36, and S845A mice, LFS-LTD is impaired because AKAP-PKA anchoring and S845 
phosphorylation are needed to promote transient recruitment of CP-AMPARs to CA1 




CaN103,104,169,172. These LTD findings at CA1 synapses are in accordance with studies in 
other brain regions, including in the amygdala, ventral tegmentum, and nucleus 
accumbens, where CP-AMPAR synaptic incorporation not only supports synaptic 
potentiation but can also prime synapses for LTD/de-potentiation201,355. Accordingly, in 
CS mice basal CP-AMPAR incorporation may prime synapses to undergo normal LTD 
through AKAP-CaN-mediated removal with no need for additional CP-AMPAR 
recruitment. Consistent with effective synaptic removal of CP-AMPARs by LTD in CS 
mice, prior LFS induction of LTD allowed subsequent HFS induction of LTP/de-
depression to recruit CP-AMPARs back to CA1 synapses.  
AKAP palmitoylation and signaling in multiple locations during LTP and LTD  
Our prior studies found that palmitoylation of human AKAP79 is required for its 
localization to dendritic REs247,248, a compartment that is known to deliver GluA1 to the 
PM in support of LTP143,144,148. In addition, acute AKAP79 CS overexpression in rat 
hippocampal neurons increased both basal RE exocytosis and synaptic CP-AMPAR 
activity. Here, while we also observed decreased AKAP150 CS RE localization and 
increased basal CP-AMPAR activity in AKAP CS mice, we did not observe increased 
basal RE exocytosis. Thus, AKAP CS mice exhibit alterations in GluA1 CP-AMPAR 
regulation even in the absence of more widespread RE trafficking dysfunction. 
However, we found that palmitoylation is also required for normal AKAP150 association 
with the PSD, as shown by reduced co-localization and co-fractionation of AKAP150 CS 
with PSD-95. Thus, impaired LTP in AKAP CS mice is likely related to decreased AKAP 
signaling in not only REs but also the PSD. In contrast, AKAP79/150 localization to the 




by loss of palmitoylation. Thus, it is tempting to speculate that AKAP-PKA signaling that 
promotes CP-AMPAR synaptic incorporation during LTP requires AKAP localization to 
REs and the PSD to promote recycling and synaptic retention of receptors, while AKAP-
CaN signaling that removes CP-AMPARs during LTD only requires extrasynaptic 
membrane targeting.  
Accordingly, our prior work found that chemical LTP stimulation increased AKAP 
palmitoylation and localization to dendritic spines. Furthermore, overexpression of the 
AKAP79 CS mutant or knock-down of its palmitoylating enzyme DHHC2 acutely 
interfered with a number of cellular correlates of LTP in cultured neurons including spine 
enlargement, RE exocytosis, GluA1 surface delivery, and mEPSC potentiation247,248. In 
contrast, chemical LTD stimulation decreased AKAP palmitoylation and localization to 
spines in coordination with spine shrinkage. Consistent with AKAP depalmitoylation 
favoring LTD > LTP as observed here in AKAP CS mice, AKAP79 CS did not interfere 
with GluA1 endocytosis and was even more sensitive than WT to removal from spines 
by chemical LTD247. In addition, overexpression of a constitutively lipidated AKAP79 
mutant prevented both AKAP removal from spines and spine shrinkage following 
chemical LTD265. Thus, based also on our findings here ex vivo, AKAP79/150 
palmitoylation is required to support LTP but not LTD.  
However, the observation that CS, but not WT mice, robustly recruit CP-AMPARs 
recently removed by LTD back to CA1 synapses during HFS-induced de-depression 
could reflect a loss of AKAP-CaN in REs allowing for enhanced GluA1 recycling and 
synaptic incorporation mediated by a pool of PKA other than that anchored to 




loss of AKAP-CaN phosphatase signaling in REs, in addition to in the PSD, could also 
contribute to the increases in basal synaptic GluA1 surface expression and CP-AMPAR 
activity in AKAP CS mice by increasing receptors within the recycling pool and then also 
biasing PSD signaling toward receptor retention. All things considered, it is remarkable 
that such a specific perturbation of AKAP79/150 intracellular targeting caused by loss of 
palmitoylation has such a dramatic impact on synaptic plasticity, thus further 
underscoring how critical scaffold proteins and their organization of localized signaling 



























 EXPLORING FURTHER MECHANISMS OF AMPAR REGULATION IN AKAP CS 
 MICE  
Introduction 
Our previously published work characterized the phenotypes of AKAP CS mice. 
Interestingly, losing AKAP150 palmitoylation results in both a basal and activity-induced 
phenotype at the level of CP-AMPAR regulation. CP-AMPAR regulation via 
phosphorylation is very well studied and depends on mechanisms of recruitment basally 
and during activities involving AKAP-anchored enzymes1,104,275. However, we only 
examined AMPAR synaptic localization and transmission in AKAP CS mutants. It is still 
unknown if perturbing palmitoylated AKAP signaling could also influence AMPAR 
localization or occupancy within internal compartments or at the extrasynaptic 
membrane. Further, CP-AMPAR dependent LTP is specifically impaired in AKAP CS 
mice (Fig 3.9C-H) but how does this specifically affect receptor localization or function 
after LTP? Thus, our previous studies did not fully explore AMPAR-mediated 
transmission following LTP. 
In our initial characterization of AKAP CS mice, we saw a slight decrease in 
mEPSC frequency but a larger decrease in sEPSC frequency (Fig 3.5C,D). There are a 
few scenarios that can result in decreased mEPSC and/or sEPSC frequency. 
Decreased frequency can occur due to fewer synapses, however, we provided evidence 
against this by showing that there was no difference in spine number or size (Fig 3.2C-
H). We did not count active synapses, which could be achieved by staining with PSD-95 
and a presynaptic marker and counting overlapping puncta per stretch of dendrite. 




probability, but this does not seem likely because we saw no difference in PPRs in 
slices from AKAP CS animals (Fig 3.5E,G). Lower sEPSC frequency could also be due 
to decreased firing activity in the hippocampal circuit. If this is the case, could such 
decreased firing be a driving force for incorporating more CP-AMPARs, mimicking a 
homeostatic scaling phenotype? Homeostatic scaling is a form of plasticity where 
neurons can either scale-up or scale-down synaptic responses in order to maintain firing 
patterns, connectivity and other forms of plasticity (like Hebbian plasticity) over 
extended periods of time. There is precedent for AKAP79/150 signaling to be important 
for homeostatic scaling-up354. Like Hebbian plasticity, mechanisms of homeostatic 
plasticity are regulated by Ca2+ influx through NMDARs and LTCCs and are conferred 
through changes in AMPAR localization and function107,108,352,375-378, including the 
regulation of the synaptic incorporation of CP-AMPARs108,353,379,380. Our laboratory has 
shown that AKAP-anchored enzymes influence CP-AMPAR synaptic incorporation so it 
is not surprising that AKAP79/150 plays a role in scaling-up. Both the ΔPIX and ΔPKA 
AKAP mutants are unable to scale-up, due to already enhanced basal CP-AMPAR 
levels and inability to recruit CP-AMPARs to the synapse respectively354. It is unknown 
then how mislocalizing AKAP and its signaling enzymes with the CS mutation could 
influence mechanisms of homeostatic plasticity.  
Aims 
• Determine the effect of chronic activity manipulation on AMPAR function in 
AKAP150 palmitoylation mutant 
• Characterize the receptor milieu that may be contributing to altered meta-




Materials and methods 
TBOA recordings   
A baseline was established (~5 minute) in whole-cell mode with K-gluconate 
internal (in mM: 137 K-gluconate, 5 KCl, 10 HEPES, 4 ATP-Mg2, 0.5 GTP-Na2, 10 
phosphocreatine, ~280-290 Osm) followed by perfusion of ACSF containing 20 µM 
TBOA by gravity flow and recorded for up to 10 minutes with threo-β-Benzyloxyaspartic 
acid (TBOA). In the NASPM and TBOA condition, 20 µM NASPM was added along side 
the TBOA.  
Chronic NASPM treatments in culture  
20 µM NASPM was added to the media of cultures 24 hours before recording. 
Cells were returned to the incubator and recorded from ~23-25 hours post-treatment in 
standard ACSF with CsMe (Chapter III) internal. 
cLTP in culture 
 30 min pre-incubation in ACSF, then transferred to cLTP ACSF containing 2 mM 
Ca2+, 0 Mg2+, 200 µM glycine, 50 µM picrotoxin for 10 minutes and back to normal 
ACSF for 20-30 minute recovery. Controls maintained in normal ACSF with 2 mM Ca2+ 
and 1 mM Mg2+. For electrophysiology, cells were then transferred to recording ACSF 
containing TTX and picrotoxin to record mEPSCs with CsMe (see Chapter 3 Materials 








Table 4.1: Key resources table  
REAGENT or RESOURCE SOURCE IDENTIFIER 
Chemicals, Peptides, and Recombinant Proteins 
DL-threo-β-Benzyloxyaspartic acid (DL-TBOA) Tocris Bioscience Cat#1223 
Glycine Fisher Scientific Cat#BP381-5 
Tetrodotoxin (TTX) Tocris Bioscience Cat# 1078 
Picrotoxin Tocris Bioscience Cat# 1128 
NASPM trihydrochloride Tocris Bioscience Cat# 2766 






AKAP CS animals have normal extrasynaptic receptor composition.  
Previously, we found that AKAP CS mice exhibited an increase in surface GluA1 
expression in hippocampal neurons, as well as enhanced inward rectification and 
therefore CP-AMPAR contribution to baseline transmission at CA1 synapses. While in 
preliminary experiments I observed that internal stores are not lacking for GluA1-
containing receptors (data not shown) and depotentiation is successful in field 
recordings from these mice (Fig 3.10), extrasynaptic receptors need to be considered 
as well. There is a wealth of research indicating that lateral diffusion from extrasynaptic 
receptor pools contributes to recruitment of receptors to the synapse (see above in 
introduction). To understand if extrasynaptic receptor contribution or subunit 
composition was altered in the AKAP CS mutant, after establishing baseline EPSCs 
suing whole-cell patch-clamp recordings, the excitatory amino acid transporter blocker 
TBOA was applied to produce glutamate spillover that activates extrasynaptic AMPARs, 
resulting in an enhancement to the EPSC (Fig 4.1 A). There was no difference between 
WT and CS in response to activation of extrasynaptic receptors through indirect action 
of TBOA (Fig 4.1 B). Further, if the CP-AMPAR antagonist NASPM is applied during 
TBOA treatment (Fig 4.1C,D), there is also no difference between WT and CS, 
indicating that CP-AMPARs are largely not present at extrasynaptic sites in either WT or 
CS mice.  
CP-AMPAR involvement in basal transmission in AKAP CS animals. 
The basal CP-AMPAR phenotype that was observed in CS mice showed 





Figure 4.1: Normal TBOA response in AKAP CS mice. 
(A,B) WT and CS mice respond with increased evoked EPSCs in response to TBOA 
(WT n=5, CS n=6). (C,D) NASPM applied alongside TBOA does not have any effect on 
TBOA induced increase in evoked EPSCs in either WT or CS slices (WT n=8, CS n=5). 






also reflected in IEM-sensitive contributions to mEPSC amplitude (Figs 3.5A&3.6A,B). 
However, it is unclear if this is a byproduct of aberrant receptor trafficking or if the 
system relies on the enhanced signaling conferred by the increased conductance and 
Ca2+-permeability of the receptor. To start to understand the requirement of CP-
AMPARs basally, we blocked CP-AMPARs in cultures for 24 hours with NASPM and 
then recorded mEPSCs (Fig 4.2A). WT cells do not have any significant difference in 
mEPSC amplitude or frequency following chronic NASPM treatment, consistent with a 
lack of substantial signaling by synaptic CP-AMPARs under basal conditions. In 
contrast, AKAP CS cultures exhibited a significant increase in mEPSC frequency, but 
with no change in amplitude following chronic NASPM treatment (Fig 4.2B,C). This 
preliminary data indicates that CS cultures depend on CP-AMPAR transmission basally 
because when these receptors are blocked, the cells must compensate by increasing 
AMPAR transmission. 
Impaired response to cLTP in AKAP CS mouse cultures. 
Because there seems to be a disruption in proper AMPAR handling at the 
synapse, we wanted to know if CP-AMPARs could be properly delivered to the synapse 
in an activity-dependent manner in AKAP CS cultures. LTP could be failing in these 
cells due to already have having potentiated synapses and/or simply synapses already 
containing CP-AMPARs (i.e. altered meta-plastic state) that have no place to insert new 
AMPARs. Alternatively, new AMPARs that are delivered may not provide a change in 
current and/or Ca2+ influx because they are just redundantly replacing receptors with 
their same quality. We see no difference in S845 phosphorylation in CS hippocampal 





Figure 4.2: AMPAR-minis after chronic CP-AMPAR blockade and cLTP. 
DIV13-14 culture recordings from mouse hippocampal neurons from WT and CS mice. 
(A-C) 24 hours of 20 µM NASPM does not affect WT mEPSCs, but significantly 
increases AKAP CS mEPSC frequency (CS con: 1.802 ± 0.1475 Hz, CS NASPM: 4.715 
± 0.6237 Hz, ****p<0.0001, WT n=5, CS n=12)(C). (D-F) cLTP (200 µM glycine, 50 µM 
picrotoxin, -Mg2+ for 10 min) increases WT mEPSC amplitude (E) (Amplitude WT: 9.207 
± 0.3548 pA, WT cLTP: 13.71 ± 0.9802 pA, CS: 10.99 ± 0.4182 pA, CS cLTP: 15.58 ± 
1.304 pA; WT n=15, WT cLTP n=18, CS n=17, CS cLTP n= 17; WT vs WT cLTP 
***p=0.0004, WT vs CS **p=.0032, CS vs CS cLTP **p=.0021) and frequency (F) 
(Frequency: WT: 0.7033 ± 0.1165 Hz, WT cLTP: 1.19 ± 0.1623 Hz, CS: 1.388 ± 0.2252 
Hz, CS cLTP: 1.399 ± 0.1983 Hz; WT n=13, WT cLTP n=15, CS n=17, CS cLTP n=17; 
WT vs WT cLTP *p=0.0257, CS vs CS cLTP p=0.9694 [n.s.], WT vs CS *p=0.0202) 
while only affecting AKAP CS mEPSC amplitude. *p<0.05, **p<0.01, ***p<0.001, 
****p<0.00001 one-way ANOVA with Tukey’s multiple comparison test. Data are 




phosphorylation site during or after LTP/cLTP. Then again, AKAP CS mice could deliver 
GluA1-lacking receptors that would not confer synapse strengthening. Even still, we 
could be observing impaired forward trafficking of receptors in CS cells when there is a 
high demand and enhanced stress on the system due to a lack of receptors in the 
trafficking pool or a problem with insertion/diffusion mechanisms. As a preliminary 
attempt to try and approach this question, we wanted to assess activity-dependent 
AMPAR recruitment with electrophysiology. Cultures show an increase in both mEPSC 
amplitude and frequency basally in AKAP CS cultures (Fig 3.6A-C&Fig 4.2D-F), as 
observed previously. In response to cLTP, WT neurons respond with a significant 
increase in both amplitude and frequency of mEPSCs (Fig 4.2D-F), while CS neurons 
only show a significant increase in amplitude and not frequency. 
Conclusions and discussion 
We found that extrasynaptic AMPAR levels and composition appear normal in 
AKAP CS slices. Also, at 2-3 weeks of age, extrasynaptic receptors appear to be largely 
CI-AMPARs, as shown by insensitivity to CP-AMPAR blockade paired with TBOA 
treatment. While this information is important for more completely understanding the 
total surface receptor compliment and thus the extra-synaptic contribution to the meta-
plastic state of the neuron, it only tells us what is happening basally. Further work will 
need to be done to characterize lateral diffusion in the mutant, perhaps by crosslinking 
surface receptors and measuring the response to activity (as in155).  
We have just begun to think about how AKAP-mediated mechanisms of 
homeostatic scaling may be altered in AKAP CS animals. We observed in very 




frequency and a trend towards increased amplitude. This observation is intriguing and 
merits further exploration, by way of increased replicates and follow-up experiments. It 
would be interesting to observe the effect of standard scaling treatments (such as 
chronic TTX or TTX with NMDAR blockade) on CS cells, which our lab has used 
previously to understand the role of AKAP-anchored enzymes in scaling354. I predict that 
AKAP CS cells will be able to more effectively scale-down than scale-up, mimicking the 
LTD and LTP phenotypes outlined above. However, while there is considerable overlap, 
not all of the same mechanisms that control Hebbian plasticity equally control 
homeostatic plasticity. In this way, we can further understand the role of AKAP 
palmitoylation in the larger plasticity context. 
AKAP CS cultures can respond normally in mEPSC amplitude increase to cLTP, 
but not in frequency. Post-synaptically, enhanced amplitude is often associated with 
increased channel properties (like single-channel conductance) and frequency is 
associated with synapse unsilencing. With this in mind, neurons lacking AKAP 
palmitoylation could have issues unsilencing synapses, perhaps due to a problem with 
AMPAR forward trafficking and/or receptor retention at the synapse following cLTP. 
With an already enhanced mEPSC frequency, CS cells could have few silent synapses 
left to be unsilenced in response to cLTP. However, in acute slice, we observed only an 
increase in mEPSC amplitude and, in fact, a decrease in both mEPSC and sEPSC 
frequency (Fig 3.5A,B) basally. It is unclear why these differences are present. More 
experiments will need to be done to understand these differences between slice and 
culture. One huge consideration with comparing cultures to slice is that the slice 




are altered in AKAP CS intact animals in a way that could contribute a great deal to 
mEPSC/sEPSC frequency. Additionally, we previously examined the effect of NASPM 
on slices following LTP, but to more directly understand the dynamics of CP-AMPARs 
specifically in slices from WT and CS mice, we can use rectification measurements 
following the different LTP paradigms to understand if and for how long CP-AMPARs 


















 CONCLUSIONS AND FUTURE DIRECTIONS 
Broad implications 
The work in this thesis details several fundamental mechanisms of cellular and 
molecular synaptic biology. The studies here identify a molecular mechanism for 
controlling substrate phosphorylation through anchoring of scaffolding molecules near 
substrates and activity-dependent signals. Further, this thesis work shows a specific 
requirement for different types of receptors both during basal conditions and activity-
dependent plasticity. Unexpectedly, this work also identified multiple LTP mechanisms 
that differentially recruit receptors for expression. Ultimately, the current study highlights 
the importance of a single protein’s palmitoylation state using a transgenic mouse 
model that was among the first described to precisely perturb palmitoylation of an 
individual protein. More broadly, this work identifies a signaling mechanism that has the 
potential to be important for learning and memory. 
Key findings 
AKAP CS young mice display an elevated AMPAR-mediated basal transmission, 
due to the aberrant insertion of CP-AMPARs as evidenced by enhanced mEPSCs, 
increased AMPAR rectification, sensitivity to the CP-AMPAR blocker NASPM, and 
increased synaptic GluA1-AMPARs by super-resolution imaging. AKAP79/150 
palmitoylation is also important for the protein’s subsynaptic organization, with less 
AKAP in synapses in AKAP CS cultures as shown by STED imaging and biochemical 




divergent response to either CP-AMPAR dependent or independent stimuli, failing at 
CP-AMPAR dependent stimuli and competence at CP-AMPAR independent stimuli.  
AKAP CS cultures show increases in mEPSC amplitude mirroring WT cultures 
after cLTP, but no increase in frequency, unlike WT cultures. AKAP CS cultures also 
show increased mEPSC amplitude and frequency and this increase can be blocked with 
CP-AMPAR blockers. It also appears that these elevated levels of CP-AMPARs in CS 
mouse neurons are impacting basal neuronal signaling functions because, unlike WT, 
CS neurons will scale-up in response to long-term CP-AMPAR blockade.  
Remaining questions and future directions 
AMPAR trafficking and the recycling endosome 
 While the requirement of CP-AMPAR involvement during plasticity has been a 
source of confusion and even controversy, evidence of the delivery of these receptors to 
the synapse provides a platform to support hypotheses about the input-specificity of 
long-term synaptic plasticity. An attractive idea is that newly recruited receptors could 
act as a tag for recently potentiated synapses to support and initiate long-term changes 
in synapse structure, local protein synthesis and gene expression381,382. Nonetheless, 
CP-AMPAR involvement needs to be studied during different types of plasticity and 
different behavioral paradigms under specific conditions taking into consideration that 
age, brain area and stimulus intensity will affect CP-AMPAR involvement. It is still 
unknown what CP-AMPAR Ca2+ could be providing during both LTP and LTD. In a way, 
CP-AMPARs could act as indicators and influencers of meta-plastic state, acting as a 
way for synapse specific control of meta-plasticity, like the fine focus on a microscope or 




AKAP150 CS knock-in results in differential exocytosis phenotypes than what we 
previously observed with acute AKAP79 CS overexpression or DHHC2 knockdown in 
rat cells247,248. While AKAP79 CS showed elevated basal RE exocytosis and a lack of 
further cLTP-induced exocytosis with overexpression, in AKAP150 CS mice we see 
normal basal trafficking and enhancement in RE exocytosis with cLTP. This result 
makes sense if one considers that trafficking and recycling through intracellular 
pathways is important for many aspects of normal cellular function and chronic 
manipulations (i.e. knock-in) allow more time for compensation than transient 
manipulations (i.e. overexpression). Further, AMPARs are not the only endosome 
residents and the basal synaptic AMPAR enhancement we observe could be 
independent of this pathway. Alternatively, if AKAP79/150 palmitoylation is involved in 
proper delivery of AMPARs and when it is unable to be palmitoylated this forward 
trafficking could be altered via endosomal mechanisms that are specific only for 
particular cargos (such as AKAP-interacting cargos). We know that AKAP79/150 
interacts with a myriad of other synaptic proteins so there could be other proteins that 
are dysregulated in this mutant in a similar manner. We do not know the entire protein 
composition of the RE and in future it would be interesting to determine what these 
proteins are and how they may change when AKAP is unable to be palmitoylated. It 
would also be interesting to understand if AKAP interacts with different binding partners 
within different compartments, like the synapse versus at endosomes, and depending 
on its palmitoylation state. We also do not know if AKAP-anchored enzymes can signal 
at endosomes to affect the cargo, trafficking or the endosome itself. The RE is an 




The CS frequency dilemma 
We found that AKAP CS slices have decreased mEPSC and sEPSC frequency 
compared to WT. Frequency disruptions, as mentioned above, could hint at a circuit 
level disruption. If the hippocampal circuit is somehow perturbed in AKAP CS mice, this 
could initiate homeostatic plasticity mechanisms to compensate for a potential 
decreased activity level. We preliminarily observed that CS cultures highly depend on 
CP-AMPAR activity, because when CP-AMPARs are chronically blocked, there is a 
scaling-up phenotype. Still to be examined is what happens when AKAP CS cultures 
are exposed to traditional synaptic scaling conditions. We would expect if there is an 
overlap between the Hebbian CP-AMPAR dependent LTP and homeostatic scaling up 
then CS cells will either already be scaled-up or will be unable to scale-up via 
mechanisms controlling CP-AMPAR trafficking and synaptic retention. In parallel, future 
work needs to be done to characterize the intrinsic activity of CA1 neurons and other 
regions within the hippocampal tri-synaptic loop (CA3 neurons, Dentate cells) in AKAP 
CS mice. Another interesting experiment would be to study inhibitory transmission to 
see if AKAP79/150 palmitoylation also influences GABAergic synapses and neuronal 
excitability/inhibitory balance. This could provide a wealth of additional information 
about how AKAP palmitoylation affects signaling at the circuit level.  
Age-dependent and behavioral outcomes of AKAP palmitoylation disruption 
Much of the analysis of hippocampal-relevant behaviors is done in older animals 
(8 weeks+). The experiments in Chapter III and IV of this thesis describe phenotypes in 
cultures or young mice (2-3 weeks old). To understand the effect of AKAP 




AMPAR phenotype seen here in younger animals is maintained or changes with age. 
The ultimate goal is to administer a battery of hippocampal-dependent behavioral tasks 
on AKAP CS mice to determine if AKAP palmitoylation is important for learning and 
memory behaviors in vivo. 
Intact LTD: AKAP’s palmitoylation state and signaling mechanisms during LTD 
LTD is intact in CS mice but what is the mechanism of this LTD? CaMKII is 
important in both LTP and LTD383. Recently, our laboratory and others showed that LTD 
initiates AKAP79/150 depalmitoylation and subsequent removal from spines through a 
CaMKII mediated mechanism that promotes it depalmitoylation265. While we also know 
that AKAP CS is more easily removed from the membrane and spines when its 
depalmitoylated247,264 and LTD is still intact in AKAP CS mice, it is unknown if the 
mechanism of LTD in CS differs from WT. Future work will need to be done to 
determine if: this CaMKII mechanism is still intact, if the basally enhanced levels of CP-
AMPARs are removed with LTD stimulation, if a transient population of CP-AMPARs 
are recruited and/or required for LTD, and if this basal enhancement also alters meta-
plasticity with a bias toward LTD.  
Spatial and temporal control of AKAP palmitoylation 
While this study examines the effect of blocking all AKAP150 palmitoylation from 
birth, it limits the conclusions that can be drawn about dynamic AKAP palmitoylation-
depalmitoylation cycling. It will be important to study how AKAP depalmitoylation 
compares to the current approach of blocking palmitoylation through mutation. We are 
currently technically limited in our ability to study this dynamic process due to no 




be advantageous to have a system to selectively ablate palmitoylation of a particular 
protein, ideally with high spatial and temporal control. Certainly, it has become vitally 
important to understand the flip side of palmitoylation of AKAP79/150; the 
depalmitoylating PPT enzyme for AKAP still needs to be discovered. In this way, 
understanding the dynamic nature of AKAP palmitoylation will be more complete. 
This knock-in mutation approach was useful in examining the effect of altering all 
nodes of palmitoylation-targeting of AKAP. As a consequence this method limited the 
ability to parse apart contributions of AKAP palmitoylation to each individual signaling 
node, such as at the core PSD or at REs. In the future, the contribution of palmitoylated 
AKAP to these two subsynaptic locations could be studied using recruitment techniques 
(such as with a light-induced dimerization system) of AKAP either palmitoylation 
competent or incompetent to either the PSD or to REs. A technique such as this can 
help answer questions about the location dependence of signaling to specific 
phenotypic observations in AKAP CS neurons (i.e. can recruiting palmitoylation 
competent AKAP to REs or the core PSD during CP-AMPAR dependent LTP rescue the 
LTP? Or does recruiting palmitoylation competent AKAP to the core PSD provide 
enough bi-directional control by PKA and CaN to exclude CP-AMPARs basally to 
rescue the increased CP-AMPAR basal phenotype?) As for the palmitoylation field, 
further advancement in palmitoylation detection will be required to directly visualize 
palmitoylation in situ. This will not only help with monitoring in real time the 
palmitoylation state of AKAP79/150, but also with any other palmitoylated protein and 
even multiple proteins at once. It would be ideal to have an optical reporter of 
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